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Abstract 
 In neurons, kinesin1 transports vesicles, protein complexes, as well as various 
cargo assemblies toward the plus-end of microtubule tracks. This cargoes’ transport 
allows neurons to perform basic physiological functions, as cell’s maturation and 
synaptic transmission. One of the first kinesin1’s cargo identified was the JNK-
interacting protein 3/4 (JIP3/4) sub-family. Beyond cargoes’ functions, these proteins 
act as scaffolds on JNK and p38 mitogen-activated protein kinase (MAPK) cascades. 
JIP3/4 are recruited by kinesin1 through a dual binding mode. Here, we aimed to 
elucidate this characteristic recruitment, by examining one of the interfaces at the 
molecular level. The objective of this study is the structural characterization of the 
recruitment of the Leucine Zipper II (LZII) of JIP3/4 by the kinesin light chain 1 (KLC1) 
of kinesin1. Several advancements were realized. 
 During this Master’s project, KLC1 and JIP3/4 mutants were produced, purified 
and structurally characterised; this work is not yet fully completed. Identification of 
JIP3_LZII binding surface was investigated, using alanine scanning on 3 heptad repeat 
defined accordingly with a docking model. Also, encouraging preliminary studies to 
determine the low resolution 3D structure by SAXS of the complex were also 
performed. Future works will be made, aiming to complete the structural 
characterization of the KLC1-binding surface on JIP3_LZII. New JIP3_LZII mutants 
have to be produced, their structural integrity checked and their interaction with KLC1 
investigated. Finally, the 3D structure of the KLC1:JIP3/4 complex have to be 
determined by SAXS. 
 
 
 
 
 
Key words: kinesin1, KLC1, JIP3/4, cargo recruitment, Leucine Zipper, TPR domain, 
structural characterization, MST, nanoDSF, CD, crystallization. 
 
 
vi FCUP/ICBAS/I2BC 
Structural Characterization of JIP3/4 Leucine Zipper II Recruitment by kinesin1 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FCUP/ICBAS/I2BC 
Structural Characterization of JIP3/4 Leucine Zipper II Recruitment by kinesin1 
vii 
 
Index 
 
Abstract ......................................................................................................................................... v 
Index ............................................................................................................................................. vii 
List of Figures and Tables .............................................................................................................. ix 
Abbreviations ................................................................................................................................ xi 
Introduction .................................................................................................................................. 1 
1. Molecular Motors .................................................................................................................. 3 
1.1 Kinesin1 ........................................................................................................................... 3 
2. JNK-Interacting Protein (JIP) Family ...................................................................................... 5 
2.1. JNK-interacting Proteins 3 and 4 (JIP3 and 4) ................................................................ 6 
3. JIP3/4 recruitment by kinesin1 ............................................................................................. 7 
4. Previous experiments on the project. ................................................................................... 7 
5. My Master Project ............................................................................................................... 10 
Materials and Methods ............................................................................................................... 11 
Transformation ........................................................................................................................ 13 
Protein Expression Tests ......................................................................................................... 13 
SDS-PAGE................................................................................................................................. 14 
Western Blot ........................................................................................................................... 14 
Glycerol Stocks ........................................................................................................................ 15 
Solubility and Minipurification Tests ....................................................................................... 15 
Protein Expression at high scale .............................................................................................. 16 
Protein Purification ................................................................................................................. 16 
KLC1 fragments ................................................................................................................... 17 
JIP3_LZII wild type and mutants .......................................................................................... 17 
Bradford Method .................................................................................................................... 19 
Limited proteolysis .................................................................................................................. 19 
Thermal Shift Assay (TSA) ........................................................................................................ 20 
Nano Differential Scattering Fluorimetry (nanoDSF) .............................................................. 20 
Size Exclusion Chromatography - Multi-Angle Light Scattering (SEC-MALS) - performed on 
Macromolecular Interaction Platform (PIM, Gif-sur-Yvette) .................................................. 21 
Circular Dichroism (CD) ........................................................................................................... 21 
Microscale Thermophoresis (MST) – preliminary studies....................................................... 21 
viii FCUP/ICBAS/I2BC 
Structural Characterization of JIP3/4 Leucine Zipper II Recruitment by kinesin1 
 
Crystallization trials of JIP3_LZII wild type and mutants - High Throughput Crystallisation 
Laboratory - (HTX) ................................................................................................................... 22 
Crystallization trials of new KLC1 fragments ........................................................................... 22 
Results ......................................................................................................................................... 25 
Protein Production ...................................................................................................................... 27 
KLC1 fragments ....................................................................................................................... 27 
Expression Conditions Optimisation ................................................................................... 27 
Protein Purification Optimization ....................................................................................... 31 
JIP3_LZII mutants .................................................................................................................... 35 
Expression Conditions Optimisation ................................................................................... 35 
Protein Purification Optimization ....................................................................................... 39 
Protein Production already optimised .................................................................................... 46 
As a short revision… ................................................................................................................ 47 
Protein Characterization ............................................................................................................. 49 
Characterization of the Structural Integrity of KLC1 ............................................................... 49 
Characterization of the Structural Integrity of JIP3_LZII ......................................................... 56 
Protein-Protein interaction Characterization ............................................................................. 63 
Discussion and Future Perspectives ............................................................................................ 65 
Bibliography ................................................................................................................................ 71 
Annexes ....................................................................................................................................... 77 
 
 
 
 
 
 
 
FCUP/ICBAS/I2BC 
Structural Characterization of JIP3/4 Leucine Zipper II Recruitment by kinesin1 
ix 
 
List of Figures and Tables 
 
Figure 1 - Kinesin1.. ...................................................................................................... 5 
Figure 2 - Schematic representation of JIP3. ................................................................ 6 
Figure 3 - Schematic representation of the dual binding mode between kinesin1 and 
JIP3 isoform ........................................................................................................... 7 
Figure 4 - Sequence alignment of LZII domain from JIP3 and its homologous JIP4 ...... 8 
Figure 5 - Docking models for KLC1:JIP3_LZII ............................................................. 8 
Figure 6 - Expression tests of KLC1_#1. ..................................................................... 29 
Figure 7 – Bacterial lysis test of KLC1_#1 protein expression. .................................... 30 
Figure 8 - SDS-PAGE of the minipurification performed for KLC1_#1.. ....................... 30 
Figure 9 – Purification of KLC1_#1 by His-tag affinity chromatography. ...................... 32 
Figure 10 - Purification of KLC1_#1 by gel filtration chromatography .......................... 33 
Figure 11 – SDS-PAGE of KLC1_#1 batchs. .............................................................. 34 
Figure 12 - Expression tests of JIP3_LZII_#1.............................................................. 37 
Figure 13 - Lysis tests for JIP3_LZII_#1 protein expression ........................................ 38 
Figure 14 - SDS-PAGE of the minipurification performed for JIP3_LZII wild type. ....... 39 
Figure 15 – First GST-tag affinity chromatography performed for JIP3_LZII_#1. ......... 40 
Figure 16 - SDS-PAGE illustrating the results of rTEV protease activity on GST-
JIP3_LZII_#1. ...................................................................................................... 41 
Figure 17 - Elimination of His-tag contaminants. ......................................................... 42 
Figure 18 – Elimination of GST-tag contaminants. ...................................................... 42 
Figure 19 – Size exclusion chromatography results of JIP3_LZII_#1 .......................... 43 
Figure 20 - SDS-PAGE batch of JIP3-LZII purified. ..................................................... 44 
Figure 21 - Resume of JIP3_LZII purification strategy optimised. ............................... 45 
Figure 22 - Limited proteolysis experiments performed for KLC1_#1 .......................... 50 
Figure 23 - TSA results for KLC1_#1 (A) and KLC1_#3 (B). ....................................... 51 
Figure 24 - Zoom of the elution chromatogram of KLC1_#1 in a Superdex 200 10/300 
GL Increase. ........................................................................................................ 53 
Figure 25 – KLC_#1 crystallization conditions where crystals and microcrystals were 
found.. ................................................................................................................. 55 
Figure 26 - CD spectrum of JIP3_LZII_#1 ................................................................... 56 
Figure 27 - CD experiments on JIP3_LZII wild type and mutants ................................ 57 
Figure 28 – Two measures of the first nanoDSF assays, using JIP3_LZII_#10. .......... 58 
Figure 29 - nanoDSF assays using JIP3_LZII_#1 and JIP4_LZII_#1 fragments. ......... 59 
x FCUP/ICBAS/I2BC 
Structural Characterization of JIP3/4 Leucine Zipper II Recruitment by kinesin1 
 
Figure 30 – nanoDSF experiments using JIP3_LZII wild type and mutants.. ............... 59 
Figure 31 - JIP3_LZII crystallization conditions with the presence of microcrystals.. ... 62 
Figure 32 – MST experiments using labeled-KLC1_#0 and JIP4_LZII_#1.. ................ 63 
Figure 33 – Capillary Scan from MST experiments of labelled-KLC1 and JIP4_LZII. .. 64 
 
 
Table 1 – KLC1 constructs whose expression conditions were optimised. .................. 27 
Table 2 - KLC1 fragment yield after purification. ......................................................... 35 
Table 3 – List of JIP3_LZII constructs. ........................................................................ 36 
Table 4 – JIP3_LZII_#1 expression conditions selected for solubility and 
minipurification tests. ........................................................................................... 38 
Table 5 – Purification yield of JIP3_LZII mutants. ....................................................... 45 
Table 6 – rTEV, KLC1 and JIP4 fragments produced during the project. .................... 46 
Table 7 - Overview of all protein fragments produced during this project. ................... 47 
Table 8 - Buffer conditions tested for KLC1_#1. .......................................................... 52 
Table 9 - Analysis data from SEC-MALS for KLC1 fragments. .................................... 53 
Table 10 - Crystallization conditions found to KLC1_#1.. ............................................ 54 
Table 11 - Crystallization conditions of JIP3_LZII mutants. ......................................... 61 
 
 
 
 
 
 
 
 
 
FCUP/ICBAS/I2BC 
Structural Characterization of JIP3/4 Leucine Zipper II Recruitment by kinesin1 
xi 
 
Abbreviations 
Abs Absorbance 
BSA Bovine serum albumin  
CD Circular Dichroism 
CV Column volume 
GF Gel Filtration 
GFP Green-Fluorescent protein 
GST Glutathione-S-transferase 
His Histidine 
HTX High Throughput Crystallisation Laboratory 
IPTG Isopropyl-B-D-thiogalactopyranoside 
JBD JNK-binding domain 
JIP JNK-interacting protein 
KHC Kinesin high chain 
KIF Kinesin family 
KLC Kinesin light chain 
LB Lysogeny broth  
LZ Leucine Zipper 
MALS Multi-Angle Light Scattering 
MAPK Mitogen-activated protein kinase 
MST Microscale Thermophoresis 
nanoDSF Nano Differential Scattering Fluorimetry 
O/N Overnight 
OD Optical Density 
PAGE Polyacrylamide gel electrophoresis 
PBS Phosphate buffered saline  
PDB Protein Data Bank 
rpm rotations per minute 
SAXS Small-Angle X-ray scattering 
SDS Sodium dodecyl sulfate 
SEC Size exclusion chromatography 
SPR Surface Plasmon Resonance 
Tm Melting temperature 
TPR Tetratricopeptide repeat 
TSA Thermal Shift Assay 
xii FCUP/ICBAS/I2BC 
Structural Characterization of JIP3/4 Leucine Zipper II Recruitment by kinesin1 
 
 
 
FCUP/ICBAS/I2BC 
Structural Characterization of JIP3/4 Leucine Zipper II Recruitment by kinesin1 
1 
 
 
 
 
 
 
 
 
Introduction 
 
 
 
 
 
 
 
 
2 FCUP/ICBAS/I2BC 
Structural Characterization of JIP3/4 Leucine Zipper II Recruitment by kinesin1 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FCUP/ICBAS/I2BC 
Structural Characterization of JIP3/4 Leucine Zipper II Recruitment by kinesin1 
3 
 
1. Molecular Motors  
 Intracellular communication plays a very important role for cell life (Vale 2003). 
Inside of an eukaryotic (or prokaryotic) cell, there are structures called cytoskeletal 
filaments that allow the organization and communication between organelles, vesicles 
and organic molecules. In fact, beyond their structural functions, cytoskeletal filaments 
operate as tracks, allowing the traffic of vesicles, organelles, proteins and nucleic acids 
(Hirokawa 1998). Molecular motors are able to walk along these macromolecular 
assemblies. At the moment, three super-families of molecular motors have been 
identified – myosins, dyneins and kinesins (Vale 2003, Hirokawa and Takemura 2005). 
Myosins bind to actin filaments in order to perform a short-range transport below the 
plasma membrane and realize muscle contraction (Foth, Goedecke et al. 2006). On 
their hand, dynein and kinesin proteins perform  minus- and plus-end directed 
transport, along microtubules, but also motility on flagella and cilia (Karki and Holzbaur 
1999). Kinesins (also known as KIFs) transport cargoes along microtubules, using 
chemical energy from ATP hydrolysis in order to produce mechanical energy 
(conformational changes), leading to protein motion (Hirokawa 1998). Here, we focus 
on the interaction of kinesins and their cargoes. Indeed, kinesins transport vesicles, 
mitochondria, multi-protein complexes, synaptic precursors, as well as mRNAs, from a 
point to another on the cell, where these biological assemblies are requested, allowing 
different physiological functions (Hirokawa, Noda et al. 2009).  
 Nowadays, at least 45 mammalian KIF genes have been identified, leading to 
specificity on different functions and capacities to recruit cargoes. KIF genes have been 
classified into 14 classes, which represent three major protein groups, where the 
position of the motor domain is considered. Kinesins’ motor domain allows the binding 
to microtubules and the hydrolysis of ATP. They also contribute to quaternary 
organization of kinesins (Figure 1) (DeBoer, You et al. 2008).  
 
 
 
1.1 Kinesin1 
 Our case in study is kinesin1. This protein is implicated in various biological 
transport processes, on different cells’ types. Kinesin1 is a key on the bidirectional 
cargoes transport between endoplasmic reticulum and Golgi, Golgi and plasma 
membrane, as well as on the transports of lysosomes (Lippincott-Schwartz, Cole et al. 
4 FCUP/ICBAS/I2BC 
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1995, Santama, Connie et al. 2004, Woźniak and Allan 2006). Moreover, in neurons, 
this molecular motor plays main roles on growth, development and transport functions 
(Hirokawa, Noda et al. 2009). In the axon, kinesin1 guides membrane organelles and 
protein complexes from the minus-end points of the neuron cell body, along axon 
microtubule tracks, toward the plus-end terminal on the synaptic region (Bowman, 
Kamal et al. 2000). Frequently, kinesin1 uses adaptor or scaffold proteins to recruit 
their cargoes. However, this transport could also exist due to direct binding of kinesin1 
to its cargoes (Schnapp 2003). These transport functions on neurons allow their 
polarization development, neurites elongation, synaptic transmission efficiency, 
dendrites synaptic plasticity, as well as an active mitochondria distribution and mRNAs 
transport (Hirokawa, Noda et al. 2009, Hirokawa, Niwa et al. 2010). Kinesin1’s 
dysfunction on cargoes transport in neurons contributes to several diseases, as 
Parkinson, Hereditary spastic paraplegia, Ciliopathies and Alzheimer. (Gunawardena 
and Goldstein 2001, De Vos, Grierson et al. 2008, Gerdes, Davis et al. 2009).  
  
 Kinesin1 has a heterotetrameric quaternary organization with two kinesin heavy 
chains (KHC) and two kinesin light chains (KLC). Several domains have been 
implicated in cargo binding, especially the C-terminal regions of KHC and KLC chains 
(Adio, Reth et al. 2006, Gindhart 2006). Each KHC has (a) the N-terminal motor with 
ATP hydrolysis activity and microtubule binding, (b) a coiled-coil stalk domain, 
providing the ability for a successful dimerization and mechanical mobility, and (c) a tail 
domain, as a protein interacting region of the heavy chain, leading an important role on 
cargoes recruitment. KLC chains possess two different parts: (i) an alpha-helix coiled-
coil domain on N-terminal, which binds KHC stalk region and (ii) a TPR 
(tetratricopeptide repeats) domain in their C-terminal (Figure 1) (DeBoer, You et al. 
2008). In KLC’s case, the TPR domain is arranged as six TPR motifs in tandem 
involved in protein-protein interactions (Zhu, Lee et al. 2012). Indeed, the TPR domain 
of KLC is involved in cargo recruitment (Hammond, Griffin et al. 2008) (Verhey, Meyer 
et al. 2001).  
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Figure 1 – A - Kinesin1. KHC chains: on red – motor domains; on blue line – stalk regions; on yellow – tail domains. 
KLC chains are highlighted on light blue. Adapted from (Hirokawa, Niwa et al. 2010). B – Schematic representation of 
KLC domains: N-terminal heptad repeat and the 6 TPR motifs, positioned on C-terminal of KLC. 
 
 During the last years, the motor domain of kinesin1 has been well characterized 
(Kaan, Hackney et al. 2011). However, less is understood about cargoes recruitment 
and recognition by C-terminals of KLC and KHC domains. The goal of this study is to 
understand, in a structural point of view, how kinesin1 recruits their cargoes. 
 
 
2. JNK-Interacting Protein (JIP) Family 
 JNK-Interacting Proteins (JIP) are scaffold proteins, which co-localize signalling 
module components, controlling cellular processes including differentiation, growth, 
immune response and apoptosis. Precisely, JIPs have these functions on JNK and p38 
mitogen-activated protein kinase (MAPK) cascades (Morrison and Davis 2003). These 
signalling pathways are evolutionarily conserved on cells and, in mammals, two JIP 
sub-families were described (JIP1/JIP2 and JIP3/JIP4) (Yasuda, Whitmarsh et al. 
1999).  All JIPs are found in the cytoplasm of the cells, but also nuclear localization has 
been observed. JIP family possesses a considerable domains’ diversity, allowing also 
the regulation of other cell’s functions (Whitmarsh 2006). In neurons, JIPs act also in 
6 FCUP/ICBAS/I2BC 
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the regulation of axonal vesicle transport, via adaptor proteins for anterograde and 
retrograde transport on axons. JIP3 and JIP4 are structurally distinct from JIP1 and 
JIP2, apart from their JNK-binding domain (Kelkar, Standen et al. 2005). Here, we will 
discuss the sub-family JIP3 and JIP4, targets of our study. 
 
 
2.1. JNK-interacting Proteins 3 and 4 (JIP3 and 4)   
 JIP3 and JIP4 have high homologous multi-domain protein sequences. On their 
N-terminus, these proteins possess two distinguished Leucine Zipper (LZ) domains, I 
and II, as well as a JNK-binding domain (JBD). On the C-terminus, a conserved 
domain is present (Figure 2).  These proteins have particular expression patterns on 
tissues. JIP4 is ubiquitously expressed in cells and JIP3 is highly expressed on 
neurons (Whitmarsh 2006). Interestingly, JIP3 plays crucial roles in these cells, not 
only as adaptor proteins for kinesins and dyneins’ recruitment, on anterograde and 
retrograde axonal transport, respectively, but also as signalling cascade transporters, 
guided by molecular motors along the axon (Kelkar, Gupta et al. 2000). Physiologically, 
JIP3 and JIP4 participate on axonal vesicle transport, axonal elongation and neuron 
regeneration, nerve injury signalling and neuronal apoptosis pathways. (Verhey, Meyer 
et al. 2001, Nguyen, Lee et al. 2005) (Cavalli, Kujala et al. 2005). In fact, JIP3/4 were 
one of the first identified protein cargoes of kinesin1 (Verhey, Meyer et al. 2001).  
  
 
 
Figure 2 - Schematic representation of JIP3, Homo sapiens. LZ - Leucine Zipper. 
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3. JIP3/4 recruitment by kinesin1 
 In neurons, JIP3/4 are recruited by kinesin1 through a dual binding mode. 
During recent past, two different and independent interaction interfaces between JIP3/4 
and kinesin1 have been identified. On the one hand, the tail domain from kinesin1 KHC 
chain directly binds to the Leucine zipper I (LZI) of JIP3/4 (Watt, Dixit et al. 2015). This 
KHC_tail:JIP3/4_LZI interface is not developed in this manuscript. On the other hand, 
the TPR domain of KLC directly interacts with the Leucine Zipper II (LZII) of JIP3/4 
(Nguyen, Lee et al. 2005, Hammond, Griffin et al. 2008). Together, these two 
interactions regulate this cargoes recruitment pathway in neurons, as well as kinesin1 
and JIPs’ functions on these cells. Independent binding interfaces co-exist, being 
predicted that the existence of both interfaces allows a higher specificity of the protein 
recruitment in case (Watt, Dixit et al. 2015). 
 
 
Figure 3 - Schematic representation of the dual binding mode between kinesin1 and JIP3 isoform. KHC_tail: JIP3_LZI 
interface is highlighted by a red square. Highlighted on green, KLC1_TPR:JIP3_LZII interface, the case in study on this 
project. 
 
 Here, we aim to structurally characterize the JIP3/4_LZII recruitment by TPR 
domain of KLC1 of kinesin1 (Figure 3, on green). Which residues are involved in each 
domain of the complex interface, on KLC1 and on JIP3_LZII? How is the 3D structure 
of the complex? These are questions that we will try to elucidate. 
 
 
4. Previous experiments on the project. 
 This project has been started by the group before my arrival. In order to 
structurally characterize KLC1_TPR:JIP3/4_LZII interface, they aim to obtain the 3D 
structure of the complex by X-ray Crystallography, as well as molecular information on 
the interaction using biophysical approaches. The group has realized a huge effort in 
8 FCUP/ICBAS/I2BC 
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order to crystallize KLC1:JIP3/4 complex; unfortunately, without success. However, 
they gained several interesting information on the interaction using biophysical 
approaches. In other word, they narrowed down the KLC1-interface region, as well as 
the JIP3/4-interface region.  
 Altogether, these information allow to propose a docking model of the complex 
(collaboration with Raphaël Guérois, I2BC). To perform it, we used the 3D structure of 
KLC1 (PDB entry: 3NF1) and a model of JIP3_LZII computed from the 3D structure of 
JIP4_LZII (PDB entry: 2W83) (Isabet, Montagnac et al. 2009, Zhu, Lee et al. 2012).  Of 
note, the LZII from JIP3 and JIP4 share high homology (Figure 4). Two different 
docking models were computed and thus two distinct interfaces were identified (purple 
and grey chains, Figure 5) for the complex.  
 
 
Figure 4 - Sequence alignment of LZII domain from JIP3 and its homologous JIP4. On the first line, coiled-coil heptad 
organization. Ten heptad repeats are represented. * - same residue; . - no similarity on the residue position. 
 
 
Figure 5 - Docking models for KLC1:JIP3_LZII. Interface 1 (purple) – major position defined; interface 2 (grey) – minor 
position defined. 
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 Then, my supervisors have realized site directed mutagenesis and affinity 
binding experiments, using KLC1 and JIP3_LZII fragments, aiming to validate one of 
the complex interfaces identified by molecular docking. Thus, the first phase of this 
project was to conceive and produce KLC1 mutants and to perform binding 
experiments with JIP3_LZII wild type. Several KLC1 mutants were designed, with 
mutation on residues from the interface 1 (JIP3 in pink, major position - Figure 5) and 
mutation on residues from the interface 2 (JIP3 in grey, minor position, Figure 5). 
Binding experiments using Surface Plasmon Resonance (SPR) and Microscale 
Thermophoresis (MST) clearly revealed that KLC1 mutations on the minor interface 
(JIP3 in grey) do not prevent interaction with JIP3, while KLC1 mutations on the major 
interface (JIP3 in pink) prevent the interaction with JIP3. These results confirmed that 
the JIP3_LZII major position is a good docking model.  
 The group aimed also to confirm the JIP3_LZII region which interacts with the 
KLC1_TPR domain using site directed mutagenesis and binding experiments (Phase 
2). To make it, several JIP3_LZII mutants were conceived. Leucine zipper motif, as 
coiled-coil, possesses a seven residues’ pattern repetition. Each heptad repeat has 
seven possible residue positions, named as a through g, where a and d are generally 
hydrophobic residues (Lupas, Van Dyke et al. 1991). Therefore, JIP3_LZII mutants 
were carefully designed because hydrophobic positions could not be mutated, in order 
to maintain the structural integrity of the Leucine Zipper domain. According with the 
molecular docking results, LZII region (predicted as interacting JIP3 surface) has to be 
tested. So, several JIP3_LZII mutation constructs were designed on the second, third 
and fourth heptad repeats, on strategic hydrophilic residues. In other words, an alanine 
scanning has been realized, in order to identify which JIP3_LZII residues are crucial for 
the complex interaction. Also a charge reversion on one putative salt bridge interaction 
between KLC1 and JIP3_LZII was conceived. Such an experiment would not only 
validate the interface, but also identify precisely a salt bridge interaction. Supposing 
this fact, this charge reversion on both residues would maintain the overall electrostatic 
forces of the complex interface, maintaining, theoretically, the complex formed. 
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5. My Master Project 
 In collaboration and with the supervision of the team, I have contributed to the 
Phase 2 of this project by optimising the expression and purification of KLC1 fragments 
and JIP3_LZII mutants. Also, I have participated on their structural characterization, by 
limited proteolysis, Size exclusion chromatography-Multi Angle Light Scattering (SEC-
MALS), Thermal Shift Assay (TSA), nano Differential Scattering Fluorimetry (nanoDSF) 
and Circular Dichroism (CD). I contributed also on KLC1:JIP3/4_LZII complex 
characterization, by performing preliminary studies using Microscale Thermophoresis 
(MST). Finally, I have performed JIP3_LZII mutants crystallization trials using the HTX 
platform, in Grenoble, France, finding several crystallization conditions. Besides, I 
found new crystallization conditions for a new KLC1 fragment, to be used on the team’s 
work. 
 Overall, KLC1 fragments and JIP3_LZII mutants were successfully produced, 
with optimised protocols. Protein characterization was not yet fully completed, but 
several experiments and optimizations were made, with very positive advancements. In 
collaboration with the team, I helped also to characterize KLC1:JIP3_LZII interaction 
and the finalization of Phase 2 of the project will be performed in the near future, using 
experiments’ optimisations here described. 
 Finally, to further confirm the docking model of the KLC1:JIP3/4_LZII complex, 
we aim to determine the 3D structure of the complex, at low resolution, using SAXS. 
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Transformation 
 In order to realize protein expression on bacterial systems, E. coli strains 
BL21(DE3)GOLD and Rosetta were transformed with KLC1 and JIP3_LZII mutant 
constructs previously conceived. After thawing 100 uL of competent cells (prepared 
accordingly with CaCl2 protocol, not shown), 40 ng expression vectors were added and 
mix was maintained on ice for 10 minutes. Thus, transformation by heat shock was 
made at 42°C, during 45 seconds. Afterwards, incubation on ice was performed during 
2 minutes. To recover transformed cells, 900 uL of new Lysogeny broth (LB) medium 
was added and an incubation of 30 minutes was made, at 37°C and 200 rotations per 
minute (rpm). Finally, 200 uL of culture were placed on LB-agar plates with antibiotic 
(50 ul/mL of kanamicin or 100 uL/mL of ampicillin, according with antibiotic resistance 
of expression vectors used). Cells were grown on agar-plates overnight (O/N) at 37°C. 
 
Protein Expression Tests 
 After transformation, a bacterial colony was picked up into 2 mL of LB medium 
within same antibiotic conditions, appropriately to antibiotic resistance of each protein 
vector. Cells were left by 3 hours at 37°C and 200 rpm. Therefore, culture was 
transferred to 50 mL of LB medium + antibiotic and incubation O/N was made at same 
temperature and rotation speed. Concerning induction conditions, a culture dilution was 
carried out to an Optical Density at 600 nm (OD600) of 0.2. Then, cells were incubated 
in order to reach the growth of OD600=0.6, at 37°C. Induction was made with 0.3 mM of 
Isopropyl-B-D-thiogalactopyranoside (IPTG). Protein expression tests were performed, 
evaluating three different induction temperatures. Incubation was performed at 30°C 
and 37°C, independently, during 4 hours, but also at 20°C O/N, all within agitation of 
180 rpm. For JIP3_LZII wild type construct, tests were performed with and without the 
presence of 1% ethanol, in order to induce stress conditions and bacterial response on 
protein expression. At the end, expression conditions were analysed using Sodium 
dodecyl sulphate polyacrylamide gels (SDS-PAGE) and Western Blot. Each protein 
sample quantity deposed was 0.1 of the absorbance unit (correspondent to 1: value of 
OD600 after induction time). 
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SDS-PAGE 
 Gels are composed by two distinct parts: a concentration gel (stacking) and a 
separation gel (running). Firstly, loading buffer (Annexe 1) was added to each protein 
fraction in the ratio of 1:5; then, protein was denatured at 95°C during 5-10 minutes. 
After, samples performed were loaded into gels, in presence of a protein marker as 
molecular weight control (Page Ruler Prestained Protein Ladder, Thermo Scientific). 
After migration, gels were stained with Instant Blue (expendeon) and washed with H2O. 
The composition of SDS gels (stacking and running) is shown on Annexe 2. 
 
Western Blot 
 Samples’ migration was performed by SDS-PAGE and proteins were 
transferred onto a cellulose membrane at 250 mA, by 1 hour, merged on transferring 
buffer (SDS Running buffer with 20% Ethanol). Aiming the protein transfer 
confirmation, membrane was coloured with Ponceau buffer (0.2% (w/v) of Ponceau 
and 10% acetic acid – red ponceau staining) and membrane was compared with the 
results of similar deposition on a blue stained SDS-PAGE. Therefore, blockage was 
made by submerging the membrane in Phosphate buffered saline x1 (PBS, Sigma), 
0.1% of Tween 20 and 5% (w/v) of Nonfat-Dried Milk bovine (Sigma), kindly agitated 
during 30 minutes at room temperature. Then, cellulose membrane was incubated with 
GST- or His-tag antibody (anti-GST peroxidase conjugate, Sigma; or Anti-His6 
Peroxidase (2), Roche) added to new blockage buffer, on the antibody/buffer volumes’ 
ratio of 1/200 and 1/3000, respectively. Incubation at room temperature was performed, 
during 1 hour, with slow agitation. Consequently, membrane wash was made in three 
times of 10 minutes, using PBS x1 and 0.1% of Tween 20. In order to obtain 
chemoluminescence detection, both GST- and His-tag antibodies possess a signalling 
domain of peroxidase activity. Substrate was prepared using Super Signal West Pico 
Chemoluminescence Substrate (Thermo Scientific) and 1 mL of it was overspread on 
the membrane. After an incubation of 3 minutes, chemoluminescence was measured 
by FujiLas-3000 equipment, performing high sensitivity and an exposure time between 
10 seconds and 1 minute, depending on the chemoluminescence signal.  
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Glycerol Stocks 
 Concerning the cryopreservation of transformed cells for future works, pre-
cultures from protein expression tests were used to make glycerol stocks. After mixing, 
we achieved glycerol’s final concentration of 40% and cells could be frozen on liquid 
nitrogen and stored at -80°C. 
 
Solubility and Minipurification Tests 
 Here, we aimed to select the protein expression conditions that allow the higher 
production of soluble protein, but also to qualitatively evaluate its purification yield. 
 For solubility tests, lysis was performed with pellets collected from expression 
tests. Lysis buffers used (Annexe 3) were enriched with 0,1% Triton, 1mM PMSF, 2 
ug/mL of leupeptin and aprotinin, 0.7 mg/mL of lysozyme, 10 units/mL of benzonase 
and 1mM DTT. The buffer volume/pellet ratio performed was 1 mL per pellet from 5 mL 
culture. Afterwards, mild agitation was performed during 1 hour at 4°C, and by 
centrifugation, soluble and insoluble fractions were separated (using a Centrifuge 
5415R, eppendorf), at 16000g and same temperature, by 30 minutes. With the aim of 
comparing different conditions, equal quantities were deposed on SDS-PAGEs and 
fractions with higher protein solubility were selected for purification tests. 
 In the interest of performing minipurification tests, 200 uL of His- or GST-tag 
resins (Ni-NTA Agarose, Qiagen, and Glutathione Sepharose 4 Fast Flow, GE 
Healthcare, respectively) were washed with, firstly, 2 mL of H2O, and secondly 2 mL of 
correspondent lysis buffer (Annexe 3), by centrifugation at 400 rpm, during 5 minutes. 
Resins were used according with tagged-proteins in study. Then, 2 mL of soluble 
fractions were added to resins and mild constant inversion of samples was made at 
4°C, by 1 hour. After similar centrifugation, not retained fractions were collected. 
Resins’ wash were made using 600 uL of wash buffer (Annexe 3) and centrifuged (at 
the same conditions), by 3 times. Finally, 100 uL of elution buffer (with high 
concentration of imidazole or reduced-glutathione, depending on the protein-tag, 
Annexe 3) was added and new centrifugation was realized, eluting the protein of 
interest from resins. Samples from all steps were analysed by SDS-PAGE and 
purification yield was qualitatively evaluated for each case.  
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Protein Expression at high scale 
 For large scale protein expression, pre-cultures were grown in LB medium O/N 
for each protein, with proper antibiotic conditions. Thus, cell growth and OD600 required 
conditions were performed, accordingly with expression tests’ results for each protein, 
into the final volume of 1L of YT medium. Induction conditions previously chosen for 
each protein were consequently used, as described on Results. Hence, cell cultures 
were centrifuged at 4000 rpm and 4°C, during 30 minutes, by a JLA-8.1000 rotor on a 
centrifuge Avanti J-26 XP (Beckman Coulter). Finally, pellets were resuspended on 
PBS x1 buffer, centrifuged again (on a Centrifuge 5330R, eppendorf) at 4000 rpm, by 
20 minutes, and pellets were stored at -20°C or directly used for protein purification. 
 
Protein Purification 
 Aiming the purification of the proteins in study, different approaches were 
performed, taking in consideration that KLC1s are His-tagged and JIP3_LZIIs are GST-
tagged. Firstly, an extraction and clarification step was carried out, concerning the 
separation of soluble and insoluble proteins, as well as other bacterial components, 
also insoluble. For that, bacterial lysis was made, using lysis buffer (dependent on each 
protein; Annexe 4) to the final volume of 50 mL/pellet of 1L culture. Lysis buffers were 
enriched by 0,1% Triton, 1mM PMSF, protease inhibitors leupeptin and aprotinin at the 
concentration of  2 ug/mL, 0,7 mg/mL of lysozyme, 10 units/mL of benzonase (Sigma) 
and 1mM DTT. After 1 hour of mild agitation at 4°C, lysate was sonicated in order to 
have a good lysis yield. Subsequently, a centrifugation was performed at 40000 rpm, 
4°C and during 45 minutes, with a TI-70 rotor, working within an Avanti J-26 XP 
(Beckman Coulter), leading to lysate clarification. Secondly, a capture step was made 
using the soluble fraction, in order to isolate and concentrate the protein of interest, by 
using Protein Affinity Chromatography. Depending on the purified protein, we 
performed different strategies. The followed protocols were realized to purify KLC1 and 
JIP3_LZII fragments. To manage all processes, an AKTA Purifier or an AKTA Pure 
system (GE Healthcare) were adopted, at 10°C. 
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 KLC1 fragments 
 KLC1s allowed their purification by His-tag Affinity Chromatography, separating 
the majority of the contaminants from the protein fragments in consideration. On the 
second step, a size exclusion chromatography was always performed, leading to 
protein polishing and an higher yield of purification, in terms of protein sample 
homogeneity, oligomerization state and contaminants elimination.  
 Previously, a 5 mL Histrap Column HP (GE Healthcare) was equilibrated with 5 
column volumes (CV) of lysis buffer (Annexe 4). After loading the column with the 
soluble fraction (at 1 mL/min and a maximum of 0.3 MPa pressure), a wash was 
performed with 5 CV, using wash buffer (Annexe 4). Then, elution was performed by 
imidazole gradient concentration, using wash and elution buffers (Annexe 4). We 
realized an imidazole gradient of 20 mM to 500 mM, during 5 CV, at same elution debit. 
Fractions were collected and analysed by SDS-PAGE. Therefore, we made a protein 
fractions selection to be concentrated (volume around 6 mL) and injected on a Size 
Exclusion Chromatography (SEC), for further purification. 
 Then, a HiLoad 16/60 Superdex 75 prep grade (GE Healthcare) was used to 
perform the polishing step for KLC1s. Column was previously equilibrated with 2 CV of 
KLC1 storage buffer (Annexe 4). Elution was made at 0.8 mL/min and a maximum of 
0.5 MPa system pressure. Fractions were collected and analysed by SDS-PAGE. 
Then, we selected KLC1 protein fractions to store on batches, considering the yield of 
purification. Protein concentration was determined by Abs 280 nm. Purified KLC1s 
were also analysed on a SDS-PAGE batch and frozen within liquid nitrogen for storage. 
 
 JIP3_LZII wild type and mutants 
 Several strategies were conceived and tried; afterwards, a strategy of 5 
purification steps was optimised and applied to all JIP3_LZII mutants. 
(a) GST-tag protein affinity chromatography 
 Firstly, a GST-tag affinity chromatography was performed in order to separate 
our GST-protein target from the other biological molecules, present in the bacterial 
soluble lysate. A 5 mL GST-trap FF (GE Healthcare) column was equilibrated with 5 
CV of lysis buffer (Annexe 4). After loading the column with the soluble fraction (at 1 
mL/min and a maximum of 0.3 MPa pressure), a wash step was performed with 5 CV, 
using wash buffer (Annexe 4). Therefore, elution was made using elution buffer, 
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containing 10 mM of reduced glutathione (Annexe 4). Fractions were analysed by SDS-
PAGE and then selected for GST-cleavage O/N. 
 
(b) JIP3_LZII-GST cleavage O/N, using rTEV 
 Protein concentration was measured by Bradford Method and rTEV His-tagged 
was added in the ratio of 1:20. rTEV used was produced by the team (protocols not 
mentioned on this manuscript). Incubation was performed at 10ºC O/N, with slow 
agitation. Samples of rTEV, JIP3_LZII GST-tagged, as well as initial and final 
incubation moments were analysed by SDS-PAGE. 
(c) His-tagged protein contaminants elimination 
 After GST- cleavage, we aimed to eliminate rTEV-His-tagged and other 
possible His-protein contaminants of the incubated protein mix. Then, a 5 mL His-trap 
Column HP (GE Healthcare) was equilibrated by 5 CV of His-buffer A (Annexe 4) and 
column was charged with the protein mixture (at 1 mL/min and a maximum of 0.3 MPa 
pressure). Flow through was collected and protein fractions were selected to be 
analysed by SDS-PAGE. Afterwards, elution of protein contaminants was performed 
from the column, using His-Buffer B (Annexe 4), and consequently eliminated. 
(d) GST-tagged protein contaminants elimination 
 By the same strategy of (c), we aimed to exclude all GST-protein contaminants 
from the selected fractions of previous step. So, we used a 5 mL GST-trap FF (GE 
Healthcare) column to realize it. After equilibrated with GST-buffer A (Annexe 4), 
column was charged (at 0.5 mL/min and a maximum of 0.3 MPa system pressure) with 
the previous selected protein fraction and flow through was recovered. New protein 
fractions were selected to be analysed by SDS-PAGE. GST-protein contaminants were 
eluted and consequently eliminated, using GTS-Buffer B (Annexe 4). Recovered 
JIP3_LZII fractions were concentrated, using Amicon Cut off 3kDa falcons (Millipore), 
to a volume around 6 mL, in order to be injected on a gel filtration column, for further 
purification. 
 (e) Size Exclusion Chromatography (SEC) 
 Finally, a HiLoad 16/60 Superdex 75 prep grade (GE Healthcare) was used to 
perform the last purification step of JIP3_LZII fragments. Column was previously 
equilibrated with 2 CV of JIP3_LZII storage buffer (Annexe 4). Elution was made at 0.8 
mL/min and a maximum of 0.5 MPa system pressure. Fractions were collected and 
analysed by SDS-PAGE gel. Then, we selected for storage JIP3_LZII protein fractions, 
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considering the yield of purification. Protein concentration was measured by Abs 280 
nm. After, fractions were concentrated using Amicon Cut off 3kDa falcons (Millipore). 
JIP3s_LZII were analysed by SDS-PAGE batch and frozen within liquid nitrogen for 
storage at -80ºC. 
 
Bradford Method 
 In order to measure each protein concentration by Bradford, two samples with 
different protein dilutions were prepared. For the first sample, protein was diluted with 
its storage buffer at 1:20 and 20 uL were added to 1 mL of Bradford reagent (Quick 
Start Bradford 1x Dye Reagent, Bio-Rad). For the second one, protein was diluted with 
storage buffer at 1:50 and 20 uL were added at the same manner. To make the control, 
1 mL of Bradford reagent was mixed with 20 uL of storage buffer. After vortex mixing, 
incubation during 5 minutes was made in the dark. Absorbance was measured at 595 
nm and concentration values were obtained due to a linear regression made with 
Bovine serum albumin (BSA - Quick Start Bovine Serum Albumin 2 mg/mL, Bio-Rad), 
measuring quantities already known, from where the linear equation was obtained: Abs 
= 1.036C, with R2=0,96763 (Abs - absorbance, C - concentration).  
 
Limited proteolysis 
 In this methodology, KLC1s were incubated, separately, with 9 different 
proteases: trypsin, alpha-chemo-trypsin, elastase, papain, subtilisin, endoproteinase 
glutamine-C, thrombin, proteinase K and rTEV. We aim to have evidences if the protein 
in study is well folded. Initially, studied proteins were diluted to 0.1 mg/mL. Respective 
concentrations were converted to Molar units and all proteases used were incubated 
with target proteins in the molar ratio of 1:500. To realize t=0 conditions for each KLC1 
fragment tested, 20 uL of diluted protein were denatured to be analysed by SDS-
PAGE. Afterwards, nine independent incubations were performed in eppendorf tubes, 
for each KLC1. On each tube, we used 100 uL of KLC1 fragment in case and proper 
quantity of each protease is added, according with the mentioned ratio. Then, we 
mixed and incubated at room temperature. Finally, different incubation moments were 
analysed: at 5, 10, 20 and 30 minutes, taking 20 uL from each incubation tube, to be 
denatured and analysed by SDS-PAGE. 
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Thermal Shift Assay (TSA) 
 For TSA experiments, KLC1 fragments were tested on different buffer 
conditions (Annexe 5) aiming the knowledge of KLC1s’ melting temperatures and 
folding on different buffer, pH and salt conditions. To realize it, we used VWR-Axygen 
PCR microplates and, to cover them, Optical adhesive Covers (Applied Biosystems). 
Initially, KLC1 fragments were diluted into 0.5 mg/mL. Then, 24 uL of each buffer 
condition were putted on each well and mixed with 3 uL of diluted KLC1. Therefore, 3 
uL of Sypro Orange 5x (Sigma-Aldrich) were added to each condition tested and plates 
were covered. Experiments were performed in triplicate, in order to validate the 
achieved results. Measurements were made on an iCycler iQ5 Real-Time PCR (Bio-
Rad), with excitation wavelength of 548 nm and emission wavelength of 595 nm, 
between 20ºC and 90ºC, with increments of 0.5ºC. 
 
Nano Differential Scattering Fluorimetry (nanoDSF) 
 Experiments were performed on a Nanotemper Technologies Workshop, 
organised by the group, and on the Structure, Design & Informatics Department of 
Sanofi Aventis, Vitry-sur-Seine, Paris, where time for experiments on a Prometheus 
NT.48 were kindly provided. 
 Initially, we used JIP3_LZII_#10 in order to know if it is possible to define a 
melting temperature to JIP3_LZII mutants, which contain on their N-terminal two 
tryptophan residues, capable of being followed by this methodology. Thus, we 
concentrated JIP3_LZII_#10 to 1.5 mg/mL. Protein dilutions in the ratio of 1:5 were 
realized, using a standard screening buffer (Annexe 6). Diluted proteins were loaded 
on High Sensitivity capillaries and analysed by nanoDSF. Fluorescence 330 nm and 
350 nm measures were performed between 20ºC and 95ºC. 
 After confirming the possibility of following the denaturation state of JIP3_LZII 
mutants by nanoDSF, experiments were also performed (not yet validated by triplicate 
measures) for all JIP3/4_LZII fragments and mutants in study. We performed similar 
dilutions to test different buffers, used on SPR, CD and gel filtration protocols by the 
group. We also tested the effect of refreeze and thaw on proteins, within gel filtration 
buffer. Same capillaries and nanoDSF measures were performed (Annexe 6).  
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Size Exclusion Chromatography - Multi-Angle Light Scattering 
(SEC-MALS) - performed on Macromolecular Interaction 
Platform (PIM, Gif-sur-Yvette) 
 Protocols are not extensively explained in this manuscript. I gave my 
contribution on experiments’ preparation and analysis. I did not perform directly MALS 
protocols for JIP3_LZII and KLC1 fragments. However, main guidelines are explained. 
For KLC1 fragments, a Superdex 200 10/300GL increase was used, with debit 0.5 
mL/min of 50 mM Hepes pH 8.0 and 200 mM NaCl. The volume of 100 uL was injected 
on the column, at the concentration of 2 mg/mL. For JIP3_LZII fragments, optimizations 
are currently in progress. 
 
Circular Dichroism (CD) 
 Firstly, in order to eliminate chloride ions (from NaCl and Tris) from JIP3_LZII 
storage buffers, dialysis was made to change buffer conditions into 20 mM phosphate 
pH 7.0, 150 mM NaF and 0.05% Tween 20. Afterwards, we concentrated all JIP3_LZII 
mutants to the range of 0.5 mg/mL. CD experiments were performed on a J-810 
Spectropolarimeter (Jasco Inc.), using a circular cuvette with 100 um of optic trajectory. 
We performed all measures between 180 nm and 260 nm, continuously, with a 
scanning speed of 50-100 nm/min, at room temperature. Concerning the calculation of 
protein secondary structure prediction percentages for JIP3_LZII mutants, an average 
was calculated with CDSSTR (theoretical database software chosen for the case in 
study) results, based on two basis set options (SDP42 and SDP48), chosen 
accordingly with the theoretical prediction of JIP3_LZII structure. 
 
Microscale Thermophoresis (MST) – preliminary studies 
 Protein interaction assays were performed, by MST, using JIP4_LZII_#1 and 
KLC1_#0. Experiments were realized on a Monolight NT. 115 Instrument (Nanotemper 
Technologies). KLC1 was labelled with kit MO-L002 Monolight Protein Labeling Kit 
Green-NHS (amine reactive, Nanotemper Technologies), maintaining its buffer, 
accordingly with manufacturers protocols. In the final, fractions of labelled protein were 
collected and concentrations were determined by Abs 280 nm. The more concentrated 
KLC-labelled fraction was diluted and used on KLC1:JIP4_LZII MST assays at the 
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initial concentration of 1,5x10-7 M (in 50 mM HEPES pH 7.0, 350 mM NaCl, 0.05% 
Tween 20 and 5 mM MgCl2). Non-labeled protein, JIP4_LZII, was used at the initial 
concentration of 715000 nM (in 50 mM Hepes pH 7, 50 mM NaCl, 5 mM MgCl2, 0.06% 
LDAO, 1 mM DTT) and sixteen dilutions were realized, according with Nanotemper 
protocols. Measures were performed using 40% MST Power and 90% LED Power, 
also with standard MST program parameters. 
 
Crystallization trials of JIP3_LZII wild type and mutants - High 
Throughput Crystallisation Laboratory - (HTX) 
 All JIP3_LZII mutants were concentrated in the order of 1 mg/mL, frozen, and 
sent to High Throughput Crystallisation Laboratory - (HTX), Grenoble, France. Each 
mutant was tested by vapour diffusion sitting drop. We requested sitting drop 
crystallization assays for each mutant in two different temperatures, 4ºC and 20ºC, as 
well as in two different crystallization screening kits: Classical Suit (Qiagen) and Grid 
Screen Salt (Hampton Research). Methods are not extensively described, due to their 
execution by HTX collaborators. HTX gives to users the possibility of following all 
assays due to pictures which are taken periodically, being accessible on the user 
profile of the website https://embl.fr/htxlab/index.php. High resolution scope is 
available. 
 
Crystallization trials of new KLC1 fragments 
 3D structure of KLC1 TPR domain is already published. However, we 
performed crystallization trials to new KLC1 fragments (KLC_#1, Annexe 7) aiming the 
achievement of new crystallization conditions of the protein, to be used by the 
laboratory, in the course of other projects. Here, it was always realized vapour diffusion 
hanging drop methodologies, performed in the lab, without robotic technology. Initially, 
we performed crystallization trials (1uL protein + 1 uL precipitant condition - drop; 500 
uL reservoir – 24 wells plate) with a Solubility Screening (Annexe 8), in order to know 
the range of protein concentration that could be used, but also favourable pH and salt 
conditions for crystallization. Afterwards, crystallization trials were performed using two 
different crystallization screening kits: Classical Suit and Ammonium Sulphate (AMSO4) 
Suite Screens (Qiagen). On hanging drop 48 wells plates, we mix 1 uL protein+ 1 uL 
precipitant condition on drops and 200 uL of same condition on reservoir wells. All 
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plates were conserved at 17ºC. After two weeks incubation, promising conditions were 
selected (shown on Results). Methylene Blue Solution (IZIT Crystal Dye, Hampton 
Research) was used on the main crystal condition found, aiming the confirmation of 
protein crystals’ formation. Optimisations are currently in course. 
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Protein Production 
 
KLC1 fragments 
 Expression Conditions Optimisation 
  
 Protein expression tests - Protein expression conditions were optimized for 
KLC1 constructs and high scale protein production was performed. Figure 6 shows that 
KLC1_#1 (Table 1) is well expressed in E. coli Rosetta. For the remaining KLC1 
constructs (Table 1), the results of expression tests were similar (not shown). In the 
case of KLC1_#1 construct, two E. coli Rosetta conditions were tested to realize 
solubility and minipurification assays: (i) 0.3 mM IPTG induction at 20ºC, O/N, and (ii) 
0.3 mM IPTG induction at 30ºC, during 4h. SDS-PAGE and Western Blot were made in 
order to select which condition allows the major production of the target protein and the 
minor production of protein contaminants (Figure 6). To perform this qualitative 
comparison, the same quantity of bacterial lysate was denatured and deposed on gels, 
for all samples.  
 
Table 1 – KLC1 constructs whose expression conditions were optimised. 
Protein 
Code 
KLC1 constructs Limits 
Mw 
(kDa) 
Expressio
n vector 
KLC1_#1 KLC1-rTEV-His  
206-502 
(full TPR 
domain) 
 
35,75 
pET22b 
KLC1_#2 KLC1-R228D-rTEV-His 35,75 
KLC1_#3 His-Thr-KLC1-GGS-GFP 61,92 
pET28 KLC1_#4 His-Thr-GFP-GGS-KLC1 62,59 
KLC1_#5 His-Thr-KLC1-GFP 61,72 
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Figure 6 - Expression tests of KLC1_#1. A - SDS-PAGE. B and C - Western Blot performed with the same samples from 
SDS-PAGE. On B, ponceau red staining shows the protein transferred from the SDS gel to the cellulose membrane. On 
C, His-tag immuno-detection is shown. On A, B and C it is indicated, by the followed order, the name and molecular 
weight of the protein, E. coli strains used and IPTG induction’s time and temperature. On the left of SDS-PAGE and 
Western Blot images, it is shown the molecular weight of the protein marker used, as well as during all manuscript. Bf In 
– Before IPTG Induction. 
 
 
 Solubility and minipurification assays - After, the selection of favourable 
protein expression conditions for KLC1 constructs was realized. After, solubility and 
minipurification tests were realized. Here, it is shown the results of the experiments for 
KLC1_#1. Same procedures were made for remaining KLC1 constructs (Table 1, 
results not shown). Using 10 mL of bacterial culture, cell lysis was performed and 
soluble fraction was separated by centrifugation. Figure 7 shows the results of these 
experiments and the condition of IPTG induction at 20ºC, O/N, was chosen for 
minipurification assays. This selection is based on the comparison of soluble/insoluble 
protein’s presence in each condition. 
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Figure 7 – Bacterial lysis test of the selected conditions for KLC1_#1 protein expression. The red square indicates the 
condition chosen. The green arrow indicates the presence of lysozyme, used on lysis experiments. P - Pellet (insoluble 
fraction); SF – soluble. 
 
 Figure 7 reveals that both expression conditions have a soluble/insoluble ratio 
almost similar. Therefore, both conditions are able to be selected for minipurification 
assays. We chose the first condition to realize minipurification experiments.  
The soluble fraction of KLC1_#1 was then incubated with His-tag resins (see 
Methods), followed by three washes and protein elution was realized. All samples were 
analysed by SDS-PAGE, in order to visualize qualitatively the purification yield of 
soluble protein. This strategy was followed for all KLC1 fragments (Table 1). Figure 8 
shows the minipurification results for KLC1_#1 fragments. High quantity of target 
protein was purified during elution step. 
 
 
Figure 8 - SDS-PAGE of the minipurification performed for KLC1_#1. As highlighted by the red square, high quantity of 
target protein was purified during elution. Lysozyme was eliminated during resin's washes. Bf Ind – Before IPTG 
induction; Af Ind – After IPTG induction; P - pellet (insoluble fraction); SF - soluble fraction; FT – flow through; W – 
wash; EL – protein elution. 
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 Finally, this experiment confirms that expression conditions selected for 
KLC1_#1 allow the production of relatively high quantity of soluble protein, capable of 
being purified by Histidine-tag affinity chromatography. As well, other KLC1 fragments 
(Table 1) tested gave similar results. Thus, the same expression condition was adopted 
for all KLC1 constructs which corresponds to E. coli Rosetta at 20ºC O/N, with 0.3 mM 
IPTG induction. We found, by SDS-PAGE, that the migration of KLC1_#1 corresponds 
to its theoretical molecular weight. Also, there is no target protein quantity eluted from 
the three washes. During elution, KLC1_#1 was collected with very low presence of 
contamination. 
 
 
 Protein Purification Optimization 
 In order to have a high protein purification yield, all fragments (KLC1 and 
JIP3_LZII) were purified using an Akta Purifier or Akta Pure System (GE Healthcare). 
After every purification step, fractions were selected and analysed by SDS-PAGE, 
aiming the appropriate selection of protein samples to the next purification step or to 
protein’s storage. Hereafter, both chromatogram graph (blue line) and respective SDS-
PAGE are shown for each step of the purification process.  
 
 
 The case of KLC1_#1 - After lysis and centrifugation of bacteria expressing 
KLC1_#1, a His-tag affinity chromatography with the protein soluble fraction was 
performed. Results of this first chromatography step are shown on Figure 9. Here, it is 
shown higher elimination of protein contaminants during wash step, but also, in the 
elution step, a huge peak of KLC1_#1. By SDS-PAGE, we confirmed that the elution 
peak possesses very low protein contamination. 
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Figure 9 – Purification of KLC1_#1 by His-tag affinity chromatography. A – Elution profile of the His-tag chromatography 
(blue). It is represented the wash fraction (on red), followed by the elution of the target protein (highlighted on green). B 
– SDS-PAGE of the His-tag chromatography step. As in A, wash and elution are indicated on red and green, 
respectively. 
 
  
 Elution fractions were collected (elution peak fractions between A14 and B9 as 
indicated on figure 9B), concentrated to a final volume of 6 mL, and injected on a 
HiPrep 16/60 Superdex 75 (GE Healthcare), to perform a gel filtration chromatography 
as the second purification step. 
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Figure 10 - Purification of KLC1_#1 by gel filtration chromatography. A – Elution profile of the gel filtration 
chromatography, realized on a HiPrep 16/60 Superdex 75 (GE Healthcare). B – SDS-PAGE of protein samples, testing 
the gel filtration chromatography step. Here, it is numbered each fraction sample collected. Several fractions were 
always collected in order to know where the target protein is more concentrated and well purified, with minimum 
presence of contaminants. It is also indicated two different protein batchs (lots B1 and B2) created to storage JIP3_LZII 
wild type produced. BGf –protein sample before performing gel filtration.  Ve – Elution Volume. 
 
 As shown on Figure 10A, the elution volume of KLC1_#1 fragment on the Gel 
filtration column HiPrep 16/60 Superdex 75 (GE) is around 62 mL.  On Figure 10B, two 
different protein batchs (lots B1 and B2) of KLC1_#1 are indicated, corresponding to 
low and high protein concentration, respectively. This protein batchs’ creation strategy 
is usually followed by the group, in order to separate and store similar fractions 
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(qualitatively evaluated by SDS-PAGEs, realized after the gel filtration), but also to 
have one batch highly concentrated. Finally, two different quantities of protein from 
each batch are deposed on SDS-PAGE, usually in the order of protein micrograms 
(ug), aiming a qualitative evaluation of each protein batch, before storage at -80ºC. 
Thus, we made a SDS-PAGE (Figure 11) that reveals the highly purity of KLC1_#1 with 
no presence of protein contaminants. 
 
Figure 11 – SDS-PAGE of KLC1_#1 batchs.  
  
  
 KLC1 purification: an overview - In order to have a high yield of purification, 
two different chromatography steps were performed for all KLC1 fragments. In each 
case, firstly, His-tag affinity chromatography was realized, aiming the elimination of the 
major part of the contaminants from soluble fraction of bacterial lysate. In 
consequence, a gel filtration was performed, polishing KLC1 fractions obtained before, 
aiming a high yield of protein purity and conformational homogeneity. Protocol was 
similar for all KLC1 fragments and the yield of protein production (mg of protein/ liter of 
expression culture) is shown on Table 2, as well as their storage buffer. We obtained 
two different ranges of protein yield. The presence of GFP probably stabilizes protein 
fragments produced, allowing high quantity of these proteins produced (KLC1_#3, 
KLC1_#5). On the other hand KLC1_#1, KLC1_#2 and KLC1_#4 are probably less 
stable. 
 After protein purification, all KLC1 fragments were stored in 1 mL fractions, 
frozen in liquid nitrogen and stored at -80ºC. Annexe 4 shows all the buffers used 
during the purification steps, which were also optimised. 
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Table 2 - KLC1 fragment yield after purification.  
KLC1 mutant code 
number 
Protein yield  
(mg /L) 
Storage Buffer 
KLC1_#1 74 
50 mM HEPES pH 
8.0,  
200 mM NaCl 
KLC1_#2 70  
KLC1_#3 160 
KLC1_#4 80 
KLC1_#5 152 
 
 
 
 
 
JIP3_LZII mutants 
 Expression Conditions Optimisation 
 
 Protein expression tests - Expression tests were carried out for JIP3_LZII_#1, 
wild type fragment (Table 3). We assumed an equivalent expression yield for all 
JIP3_LZII wild type and mutants, independently on the mutation. The successful of the 
strategy was proved by equivalent purification yield between the considered JIP3_LZII 
wild type and mutants (shown on JIP3 purification results). All JIP3_LZII constructs 
have human origin, consisting on JIP3 residues 416-486 and share a molecular weight 
around 35,60 kDa. They are cloned in a pGST expression vector and thus are 
produced with a GST-tag and rTEV cleavage site. 
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Table 3 – List of JIP3_LZII constructs. 
JIP3_LZII 
code 
Mutation 
position on 
coiled-coil 
Mutation 
JIP3_LZII_#1 - Wild type 
JIP3_LZII_#2 Second heptad 
Protein mutants performed by Alanine Scanning 
on the LZII heptads. #8 is the charge reversion 
mutation. 
JIP3_LZII_#3 Second heptad 
JIP3_LZII_#4 Third heptad 
JIP3_LZII_#5 Third heptad 
JIP3_LZII_#6 Fourth heptad 
JIP3_LZII_#7 Fourth heptad 
JIP3_LZII_#8 Fourth heptad 
JIP3_LZII_#9 Fifth heptad 
JIP3_LZII_#10 Third heptad 
JIP3_LZII_#11 Fourth heptad 
  
 
 As well as for KLC1 expression optimisation, the same procedures were 
performed for JIP3_LZII_#1. Here, it is also tested the presence of 1% ethanol in the 
expression conditions, aiming the induction of stress conditions and bacterial response 
on protein expression. In Figure 12A, the results of JIP3_LZII_#1 (Table 3) expression 
tests are shown. 
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Figure 12 - Expression tests of JIP3_LZII_#1. A - SDS-PAGE performed in 9 different conditions. B and C - Western 
Blot performed with the same samples from SDS-PAGE (A). On B, ponceau red staining shows the protein transferred 
from the SDS gel to the cellulose membrane. On C, GST-tag immuno-detection is shown, demonstrating the presence 
of the target protein. 
 
 
 At this point, several conditions were found as favourable to realize solubility 
and minipurification tests. JIP3_LZII_#1 possesses good expression yields in almost of 
every conditions tested. On Figure 12C, it is possible to detect and predict that there 
are also GST-protein contaminants which are present in these expression conditions. 
The followed expression conditions (Table 4) were selected for the next step, taking in 
consideration the major production of the target protein as well as the minor production 
of protein-tagged contaminants (Figure 12).  
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Table 4 – JIP3_LZII_#1 expression conditions selected for solubility and minipurification tests. 
E. coli strain 
Indution 
time 
Temperature (ºC) 1% Ethanol 
BL21(DE3)GOLD 4h 37 + 
BL21(DE3)GOLD O/N 20 - 
Rosetta 4h 37 + 
Rosetta 4h 37 - 
Rosetta O/N 20 + 
 
 
 Solubility and minipurification assays - Based on this selection, solubility 
and minipurification tests were realized for JIP3_LZII_#1. Figure 13 and 14 show the 
results of these experiments. For each condition, 10 mL of bacterial culture was lysed 
and soluble fractions were separated by centrifugation. The condition using E. coli 
BL21(DE3)GOLD, with 0.3 mM IPTG induction and temperature of 20ºC, O/N, without 
ethanol was the chosen one to be analysed by minipurification assays. This selection is 
based on the comparison of the soluble/insoluble ratio protein in each condition, after 
bacterial lysis. The goal is to select the expression condition with the higher ratio value, 
in order to obtain soluble protein target on the best quantity as possible. As it is 
demonstrated by SDS-PAGE of these experiments (Figure 13), the chosen condition 
(highlighted on red), possesses a higher quantity of target protein on the soluble 
fraction.  
 
Figure 13 - Lysis tests of the selected conditions for JIP3_LZII_#1 protein expression. The expression condition of 
BL21(DE3)GOLD, 20ºC O/N, without ethanol, was chosen (highlighted on red). In comparison with the remaining 
conditions (highlighted on yellow), the chosen condition shows higher presence of soluble protein, EtOH – Ethanol; Bf 
Ind – Before Induction; Af Ind – After Induction. P - Pellet (insoluble fraction); SF - soluble fraction. 
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 Thus, the soluble fraction of JIP3_LZII_#1 selected was incubated with GST-tag 
resins, then washed three times and protein elution was consequently realized. All 
samples were analysed by SDS-PAGE, in order to visualize, qualitatively, the yield 
purification of JIP3_LZII_#1 (Figure 14). 
 
 
Figure 14 - SDS-PAGE of the minipurification performed for JIP3_LZII_#1. As highlighted by the red square, high 
quantity of target protein was purified during elution. Lysozyme was eliminated during resin's washes. Bf Ind – Before 
IPTG induction; Af Ind – After IPTG induction; P - pellet (insoluble fraction); SF - soluble fraction; FT – flow through; W – 
wash; EL – protein elution. 
 
 Finally, we confirmed that expression conditions selected for JIP3_LZII_#1 
produce high quantity of soluble protein, capable of being purified by GST-tag affinity 
chromatography. We used the expression condition found to all JIP3_LZII mutants with 
similar results as for JIP3_LZII wild type. We found, by SDS-PAGE, that the migration 
of JIP3 fragment corresponds to its theoretical molecular weight. Also, there is no 
target protein eluted from the three washes. However, a significant protein contaminant 
was eluted with JIP3_LZII_#1, during the elution step.  
 
 
 
 Protein Purification Optimization 
 
 The case of JIP3_LZII_#1 (wild type) - The description presented is similar to 
all JIP3_LZII mutants and, here, I show the results for JIP3_LZII_#1.  
 The first purification step is an affinity chromatography using GST-trap. This 
step allowed to collect the protein of interest, but also a GST-protein contaminants of 
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lower molecular weight, as shown on Figure 15. Collected fractions contain high 
quantity of the target protein; however, an important GST-contaminant around of 25 
kDa is present in the elution. As confirmed on its expression tests, by western blot, this 
protein contaminant possesses GST-tag, which represents a difficulty to highly purify 
the target protein. However, high quantity of JIP3_LZII_#1, GST-tagged, was collected. 
 
 
 
 
Figure 15 – First GST-tag affinity chromatography performed for JIP3_LZII wild type. A – Elution profile detected by Abs 
280nm (blue line). B – SDS-PAGE showing the results of this chromatography step. It is highlighted on red the samples 
collected and tested from JIP3_LZII_#1 elution.  
 
 Thus, I collected desirable protein fractions, mixed them and quantified by 
Bradford methods. I added rTEV protease with a ratio of 1:20, in order to cleave and 
eliminate the GST-tag from JIP3_LZII_#1. Therefore, protein sample and protease 
were incubated at 10°C, O/N. The protease products are illustrated on Figure 16.  
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Figure 16 - SDS-PAGE illustrating the results of rTEV protease activity on GST-JIP3_LZII_#1. It is shown rTEV and 
JIP3_LZII_#1 samples separated, as well as the proteolysis at t=0 and O/N. After cleavage O/N by rTEV, there were 
several protein products, identified on the figure. The target protein (JIP3_LZII) is highlighted on red. 
 
 In order to eliminate rTEV, which is His-tagged, I performed a second affinity 
chromatography using 5mL His-Trap column. Interestingly, this step of purification 
should also remove His-protein contaminants. During the purification optimisation 
process, we found that it is essential to perform this chromatography, aiming the total 
elimination of the protease contamination products. Then, in order to eliminate GST-
tagged contaminants (GST, contaminant GST-tagged fragments and JIP3 with GST-
tag not cleaved), I realized the second GST-trap chromatography (third affinity 
chromatography step). In both His-trap and GST-trap steps, the flow through was kept 
since JIP3_LZII_#1 (already cleaved) is retained neither by His- nor by GST- columns. 
These steps highly reduce the quantity of contaminants which were with the protein 
target, as shown on Figure 17 and 18.  
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Figure 17 - Elimination of His-tag contaminants. His-tag chromatography performed in order to eliminate rTEV and all 
possible His-tag products from the protein sample. On A, protein elution profile (blue line) of the chromatogram, 
indicating the flow through fractions recovered. On B, analysis of protein samples collected on flow through, by SDS-
PAGE. Af TEV – protein sample after rTEV cleavage 
 
 
 
 
Figure 18 – Elimination of GST-tag contaminants. GST-tag chromatography performed aiming the elimination of all GST 
contaminants. On A, protein elution profile (blue line) of the chromatogram, indicating the flow through fractions 
recovered.  On B, analysis of protein samples collected on flow through, by SDS-PAGE. Af His-trap – protein sample 
collected from the His-trap flow through. 
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 After recovering the selected flow through protein fractions (on His- and GST-
tag affinity chromatographies), I concentrated JIP3_LZII_#1 fractions into 6 mL (as 
described), allowing its injection on a gel filtration column HiPrep 16/60 Superdex 75 
(GE Healthcare). During this final chromatography step, there were two different elution 
volumes where contaminants were eliminated, and finally JIP3_LZII_#1 was eluted, 
starting at the column elution volume around of 100 mL, until the final of the column 
volume, corresponding, theoretically, to a globular protein of the molecular weight 
around 8-10 kDa. Size exclusion chromatography results are shown on Figure 19. 
 
 
 
Figure 19 – Size exclusion chromatography results of JIP3_LZII_#1. On A, B and C, it is highlighted by blue and orange 
arrows, two protein elution peaks, corresponding to different contaminant elution volumes (around 50 and 65 mL). On 
green, it is highlighted JIP3_LZII elution, from the volume of 100 mL until the final of the size exclusion column volume. 
A and B – SDS-PAGE showing the different elution moments from the size exclusion elution step. On red square, 
JIP3_LZII_#1 is highlighted. C – Size exclusion chromatogram. Protein elution was better followed by Abs254 (red line).  
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 Finally, I collected and tested protein samples from the third elution 
moment (highlighted by a red square on figure 19B). I measured JIP3_LZII_#1 
concentration by Abs 280 nm and concentrated it for storage. I also performed a 
gel batch (Figure 20), aiming a qualitative analysis of the protein purity, before 
storage at -80ºC. I deposed two different JIP3_LZII_#1 quantities and compared 
also with same BSA quantities. On the figure, similar protein band intensities 
were detected, between JIP3_LZII_#1 and BSA, in the respective quantities (1 
and 2 ug). This evidence allowed a qualitative confirmation that concentration 
measures of this protein by Abs 280 nm highly approaches its real 
concentration value. 
 
Figure 20 - SDS-PAGE batch of JIP3-LZII purified.  
 
 JIP3_LZII purification: an overview - After several trials and different 
protocols and strategies tested, JIP3_LZII_#1 was purified successfully, with very low 
contamination. Therefore, the same protocol was used for all JIP3_LZII mutants. Five 
different protein purification steps were required, as explained above to the case of 
JIP3_LZII_#1, also summarized on Figure 21. On the scheme, each purification step is 
illustrated, as well as the loss of protein quantity by the represented arrows, between 
each purification step realized. 
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Figure 21 - Resume of JIP3_LZII purification strategy optimised. Chr. - Chromatography 
 
 On Table 5, I present the list of JIP3_LZII mutants that we purified and their 
yield (mg of protein/L of bacterial culture).  
 
 
Table 5 – Purification yield of JIP3_LZII mutants. Storage buffer is also indicated. 
JIP3_LZII mutants 
Purification yield (mg of target 
protein/L of bacterial culture) 
Storage Buffer 
JIP3_LZII_#1 0,90 
50mM Tris pH 8.0, 150 
mM NaCl, 0,05% 
Tween 
JIP3_LZII_#2 1,18 
JIP3_LZII_#3 0,94 
JIP3_LZII_#4 0,50 
JIP3_LZII_#5 2,00 
JIP3_LZII_#6 0,70 
JIP3_LZII_#7 0,28 
JIP3_LZII_#8 1,17 
JIP3_LZII_#9 1,05 
JIP3_LZII_#10 0,92 
JIP3_LZII_#11 1,03 
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 All the strategy was optimised, taking in consideration the importance of 
having highly purified protein, with no contamination. During all JIP3s’ protein 
purification, a high level of purity was achieved; however, their yield (mg of 
purified protein/ liter of bacterial culture) is weak, also due to a high number of 
purification steps performed. Despite of low JIP3_LZII yield, important quantities 
of all protein mutants were produced and used successfully, as described on 
the next topics. 
 Interestingly, we found that the yield of JIP3_LZII_#7 is lower, comparing 
with other JIP3_LZII fragments. Generally, the value for JIP3_LZII fragments is 
around 1 mg/L. However, JIP3_LZII_#7 shows a purification yield of 0.28 mg/L. 
 All buffers used during these JIP3_LZIIs’ purification are indicated on 
Annexe 4. 
 
 
Protein Production already optimised 
 During the course of the project, I performed the production and purification of 
other KLC1 fragments, as well as JIP4 fragments, whose expression and purification 
protocols were already optimised on the laboratory. Their expression and purification 
protocols are not mentioned on this report because they were not relevant for the 
project in study. These proteins were used for KLC1:JIP3/4 interaction experiments 
(MST, SAXS). Also, I produced rTEV protease to handle during JIP3_LZIIs’ purification 
protocol. 
 On Table 6 these proteins are presented, as well as their storage buffers. 
Table 6 – rTEV, KLC1 and JIP4 fragments produced during the project.  
Protein Code Protein fragments Storage Buffer 
rTEV His-rTEV 
 
50 mM Tris pH 8.0 ; 200 mM 
NaCl ; 25% glycerol, EDTA 
DTT 1mM pH 8.0 and DTT 
1mM pH 8.0 
KLC1_#0 His-KLC1-TPR6 
 
50mM HEPES pH8; 200mM 
NaCl 
JIP4_LZII_#1 His-JIP4-WW 
 
50 mM HEPES pH7, 50 mM 
NaCl, 5 mM MgCl2, 0,05% 
Tween20, 1 mM DTT 
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As a short revision… 
 Table 7 shows all protein fragments for which production and purification have 
been described previously. Altogether, these proteins have been used for protein 
characterization and protein-protein interaction experiments. 
 
Table 7 - Overview of all protein fragments produced during this project. 
Protein fragments 
handled  during 
the project 
Protein Code 
KLC1s 
KLC1_#0 
KLC1_#1 
KLC1_#2 
KLC1_#3 
KLC1_#4 
KLC1_#5 
JIP3_LZIIs 
JIP3_LZII_#1 
JIP3_LZII_#2 
JIP3_LZII_#3 
JIP3_LZII_#4 
JIP3_LZII_#5 
JIP3_LZII_#6 
JIP3_LZII_#7 
JIP3_LZII_#8 
JIP3_LZII_#9 
JIP3_LZII_#10 
JIP3_LZII_#11 
JIP4_LZII JIP4_LZII_#1 
His-rTEV rTEV 
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Protein Characterization 
 
 We aimed to structurally characterize all the fragments produced in order to 
have information about structural integrity, stoichiometry of the protein, but also to find 
better buffer conditions to handle with them. 
 
 Characterization of the Structural Integrity of KLC1 
  
 Limited proteolysis experiments of KLC1 fragments: overview - In the 
course of this project, I performed limited proteolysis for KLC1_#1, KLC1_#3 and 
KLC_#4. KLC_#5 was not yet tested. For the protein mutant KLC1_#2, it was 
considered that its point mutation would not affect its folding. KLC1 proteins tested had 
similar results.  
 We aimed, performing this methodology, to have evidences of the correct 
protein fragments’ folding. Here, it is described the results for KLC1_#1, which was 
incubated, separately, with 9 different proteases (with different cleavage sites; see 
Materials and Methods). In these experiments, it is shown by SDS-PAGE (Figure 22) 
that KLC1_#1 was resistant to proteolysis, maintaining its molecular weight. Thus, 
KLC1_#1 is not sensitive to these 9 proteases, suggesting that it is well folded. 
Interestingly, KLC1_#1 and KLC1s tested possess a proteolysis cleavage site to 
eliminate His-tag. Theoretically, rTEV should cleave KLC1_#1 and thrombin should 
cleave KLC1_#3 and KLC1_#4. For these fragments, it was also tested O/N incubation 
(results not shown) and we found different proteolysis yields in these cases. Therefore, 
we assume that, for these KLC1 fragments, proteolysis cleavage sites conceived for 
His-tag elimination are not completely accessible on the surface of the proteins. During 
the incubation time of 30 minutes, no protease activity was reported. Also, with O/N 
incubation, different results were obtained. 
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Figure 22 - Limited proteolysis experiments performed for KLC1_#1. In A, B and C, SDS-PAGEs are shown and 
indicated for each sample the time of exposure (T/min) of KLC1_#1 to each protease. 
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 Thermal Shift Assays of KLC1 fragments - I performed Thermal Shift Assay 
on KLC1_#1 and KLC1_#3 fragments, aiming to have information about the melting 
temperature and thus, indirectly, on folding stability of these fragments on different 
buffer conditions. Also, the main purpose is to find the better buffer conditions where 
proteins will be stable, allowing to perform biophysical experiments. Figure 23 shows 
the melting temperatures calculated (mean from triplicate measures) for proteins in 
study. Numbered buffers used as TSA conditions tested and detailed results are 
described in Annexe 5. 
 A 
 B 
Figure 23 - TSA results for KLC1_#1 (A) and KLC1_#3 (B). 
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 According to the results (best conditions shown below on Table 8), KLC1_#1 
has melting temperatures in the range of 55-59°C, showing very high stability in the 
presence of Hepes pH 7.0 or Tris pH 8.0 and in the range NaCl concentration of 0.2-
0.5 M, or 0.2 M KCl. 
 
Table 8 - Buffer conditions tested for KLC1_#1, by TSA, with higher melting temperatures. These values were 
calculated taking in consideration a triplicate measurement of each sample. It is shown their average and standard 
deviation. s (Tm) – standard deviation of melting temperatures registered. 
Buffer /50 mM NaCl /M KCl /M Tm /°C s (Tm) /ºC 
Hepes pH 7.0 
0,2 
0 
55,13 0,17 
0,5 58,44 0,09 
0 0,2 55,71 0,09 
Tris pH 8.0 
0,2 
0 
55,16 0,09 
0,5 58,49 0,09 
0 0,2 55,61 0,00 
Glycine pH 9.0 0,5 0 57,52 0,09 
  
  
 Due to the results achieved, KLC1 storage buffer (50 mM Hepes pH 8.0; 
200mM NaCl) was maintained after Thermal Shift Assay experiments. These buffer 
conditions were already satisfying, keeping the folding stability of the protein. 
 Concerning KLC1 constructs fused to GFP (KLC1_#3 tested), it was 
established melting temperatures in the range of 80ºC. We expected to have two 
melting temperatures, correspondent to KLC1 and GFP parts of the protein-fusion. 
However, it was found that the fusion of GFP fragment to KLC1 increases the melting 
temperature of the overall protein. Probably GFP stabilizes KLC1, through direct 
interaction. Thus, it is not possible to obtain conclusive results in terms of buffer 
conditions and the correct folding of the KLC1 part of the protein-fusion. Thus, it was 
assumed that same conditions as for KLC1_#1 would be also favourable. 
 TSA experiments were also realized for JIP3_LZII fragments, however without 
significant results. Considerable quantity of Tween 20 is present on the storage buffer 
of these proteins. This chemical detergent highly interferes in the results of TSA, 
probably interacting directly with Sypro Orange. Both have hydrophobic characteristics. 
Therefore, Thermal Shift assays were not adopted for JIP3_LZII. 
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 SEC-MALS experiments of KLC1 fragments - KLC1_#1, KLC_#3 and 
KLC_#4 fragments, similarly with limited proteolysis, were tested in order to 
characterize the molecular mass of the proteins in solution, and thus their oligomeric 
state. SEC-MALS analysis allowed the confirmation of the homogeneity and the 
monomeric state of KLC1 fragments tested. The theoretical molecular weight of KLC1 
fragments is similar to measured values by this technique. Below, on the Table 9, 
results are shown and, on Figure 24, the graphical analysis for protein KLC1_#1 
(remaining graphical results not shown). Of note, KLC1_#3 and KLC1_#4 are fused 
with GFP (26.8 kDa). 
 
Table 9 - Analysis data from SEC-MALS experiments performed for KLC1 fragments. For all cases, there was only a 
single KLC1 elution peak. Values between parenthesis are correspondent to the maximum values of light diffusion. 
 
KLC1_#1 KLC_#3 KLC_#4 
Theoretical 
Molecular Weight  
35.6 kDa 66.3 kDa 62.4 kDa 
Peak limits (mL) 
15.014 – 16.301 
(15.527) 
13.282 – 15.104 
(14.023) 
13.492 – 15.139 
(14.121) 
dn/dc (mL/g) 0.183 0.183 0.183 
Mean of Molecular  
Weight (kDa) 
39.79 ± 0.17  (40.04) 65.07 ± 0.16  (66.29) 
62.09 ± 0.15  
(6.244) 
Hydrodynamic 
radius 
1.9 ± 0.2 (1.9) 2.8 ± 0.2 (3.0) 2.4 ± 0.2 (2.5) 
 
 
Figure 24 - Zoom of the elution chromatogram of KLC1_#1 in a Superdex 200 10/300 GL Increase. Red line: light 
scattering; Dashed line: dRI signal; pointed line: UV 280 nm signal. 
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 There were two KLC1 fragments which were not tested by SEC-MALS. For the 
protein KLC1_#2, it was predicted by its 3D structure (already known, see Introduction) 
that the point mutation would not affect its protein folding. This residue is in the tight 
turn that connects helix 1 to helix 2 of the TPR1 motif of the TPR domain. The side 
chain of the arginine is exposed toward the solvent making no interaction with other 
residues on the TPR domain.  
  
 Protein Crystallization assays of KLC1_#1 - Protein KLC1_#1, produced and 
characterized in the course of this project, was used also in other laboratory’s project. 
The 3D structure was already published, and here, the goal was to obtain protein 
crystals with a X-ray resolution less than 3.0 Å, aiming to perform peptide soakings with 
other partner (for other project of the lab, not developed in this report). 
 I realized crystallization trials and obtained two interesting conditions that I tried 
to optimise. On the Table 10, as well as in Figure 25, it is shown KLC1_#1 
crystallization conditions where crystals and microcrystals were found. 
 
Table 10 - Crystallization conditions found to KLC1_#1. To be optimised. 
Correspondent on 
Figure 25 
KLC1_#1 Precipitant conditions 
Temperature 
(ºC) 
A, B 
0.1 M Citric Acid pH 5.0, 1.6 M 
AMSO4 17 
C 0.2 M K Fluoride, 2.2 M AMSO4 
 
 Until the moment, it was considered that KLC1_#1 crystallization condition 
(0.1M Citric Acid pH 5.0, 1.6 M AMSO4) should be firstly optimised, due to the crystal 
formation (Figure 25 A, B). Using Methylene Blue Solution (IZIT Crystal Dye), it was 
proved (by the entrance of methylene blue into the crystal) that this condition allows to 
achieve protein crystals and not salt crystals (Figure 25B). Currently, laboratory is 
working on optimising this crystallization condition, but also the second one (Figure 
25C) should be taken in consideration in the near future.  
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Figure 25 – KLC_#1 crystallization conditions where crystals and microcrystals were found. A - Protein crystal from the 
condition 0.1 M Citric Acid pH 5.0, 1.6 M AMSO4. B – Same protein crystal shown on A, after testing it with IZIT Crystal 
Dye, confirming that it is a protein crystal, due to its change of color. C - Protein microcrystals from the condition 0.2 M K 
Fluoride, 2.2 M AMSO4. 
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Characterization of the Structural Integrity of JIP3_LZII 
 
 Circular Dichroism assays of JIP3_LZII_#1 and mutants - Concerning the 
secondary structure prediction of JIP3_LZII_#1 and its mutants (fragments designed 
with 78 residues), circular dichroism was realized. Figure 26 shows the CD spectrum of 
JIP3_LZII_#1, where this profile clearly demonstrates that this fragment possesses 
alpha-helix structure. 
 
Figure 26 - CD spectrum of JIP3_LZII_#1. 
  
 It is possible to determine if these mutations are affecting or not their secondary 
structure. Results were very conclusive and validated by two different calculation 
methods. The major sequence part (70-80%) of the JIP3_LZII fragments is folded as 
alpha-helix, corresponding to 54-62 residues of the fragments. In fact, evidences are in 
agreement with the theoretically previewed. JIP3_LZIIs conceived possess an N-
terminal linker (containing 11 residues where the WW motif is located) which is not 
belongs to LZII domain. We could assume that the entire LZII domain (67 residues) is 
correctly folded, as alpha-helix. Only JIP3_LZII_#7 (measured two independent times – 
1 and 2) shows no alpha-helix as significant part of the protein fragment. Therefore, it is 
concluded by CD experiments that this point mutation modifies the secondary structure 
of the overall protein (low alpha-helix structure percentage prediction, around 35%, 
which corresponds to 27 residues).Theoretically, the interaction KLC1:JIP3_LZII_#7 
should be affected. On Figure 27, it is shown a graphic with the results for all JIP3_LZII 
fragments designed. Values shown on Figure 27 are present also on Annexe 9. 
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Figure 27 - CD experiments on JIP3_LZII wild type and mutants. It is represented, for each mutant, the percentage of 
alpha-helix (blue), beta-sheet (red), turns (green) and random conformation (purple). Calculations were performed by an 
average of CDSSTR (theoretical database software chosen for the case in study) results, obtained from two basis set 
options (SDP42 and SDP48). 
 
 nano Differential Scanning Fluorimetry assays of JIP3/4_LZII, preliminary 
studies - Here, we performed preliminary studies on JIP3/4_LZII mutants using 
nanoDSF. 
 JIP3_LZII mutants possess two tryptophan residues (WW motif) in the linker 
region connecting to the GST tag; after removal of the GST-tag with rTEV protease, the 
WW motif remains with JIP3_LZII. JIP4_LZII was also conceived with WW motif. 
Furthermore, as we expect all JIP3/4_LZII fragments to be dimer coiled-coils, WW 
motif from each monomer should face together and dissociation of the dimer during 
denaturing process should give significant tryptophan fluorescence signal. This 
methodology could be applied for JIP3/4_LZII mutants. The presence of Tween 20, 
detergent which stabilizes the hydrophobic regions of JIP3/4_LZII fragments, would not 
affect the results on these assays. 
 Firstly, we performed these experiments with a JIP3_LZII mutant 
(JIP3_LZII_#10, with a buffer screening – Figure 28 and Annexe 6) in order to 
understand if it could be possible to achieve the expected results. We confirmed 
optimal fluorescence signal by one defined peak in each condition, probably due to the 
dimer dissociation. In this assay, we obtained melting temperatures in the order of 30º-
35ºC. Probably these values are in agreement with low stability of JIP3_LZII. 
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Figure 28 – Two measures of the first nanoDSF assays, using JIP3_LZII_#10. It is shown two of the melting 
temperatures obtained. 
 
 Afterwards, we compared dimer stabilities between JIP3_LZII_#1 and 
JIP4_LZII_#1, as well as between JIP3_LZII mutants, in the buffer conditions used in 
other experiments (Annexe 6). The obtained results are an indication of the stability (Kd 
of dimerization) for JIP3/4_LZII mutants, tested on three different buffer conditions and 
a fourth condition of refreeze and thaw the proteins in study. 
 To the case of JIP3_LZII_#1 and JIP4_LZII_#1, it is shown that, for each 
condition, JIP4_LZII fragment has a melting temperature around 20ºC higher than 
JIP3_LZII_#1, with 55ºC of melting temperature value. Therefore, even without 
validation, we can predict that JIP4_LZII_#1 fragment is more stable than JIP3_LZII_#1 
(Figure 29). Of note, JIP3_LZII_#1 and JIP4_LZII_#1 have the same limit size, same 
sequence at the N-terminus after cleavage and both are wild type. 
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Figure 29 - NanoDSF assays using JIP3_LZII_#1 and JIP4_LZII_#1 fragments. Melting temperatures were calculated, 
based on the first inflection point from derivation of the ratio F350/F330. Different buffer conditions were tested. GF – gel 
filtration and storage buffer; CD – circular dichroism buffer; SPR – surface plasmon resonance buffer; GF freeze – same 
GF buffer, after refreeze and thaw proteins. 
 
 Finally, we also realized experiments for JIP3_LZII mutants. On Figure 30, it is 
represented the overall results in each buffer condition tested on JIP3s (GF - gel 
filtration and storage buffer; CD – circular dichroism buffer; SPR - Surface Plasmon 
Resonance buffer (experiments mentioned on Discussion chapter); GF freeze – gel 
filtration buffer conditions after a second protein thaw).  All tested buffers are described 
on Annexe 6. 
 
Figure 30 – nanoDSF experiments using JIP3_LZII wild type and mutants. Melting temperatures were calculated, based 
on the first inflection point from derivation of the ration F350/F330. Different buffer conditions were tested. GF – gel 
filtration and storage buffer; CD – circular dichroism buffer; SPR – surface plasmon resonance buffer; GF freeze – same 
GF buffer, after refreeze and thaw proteins. 
 
 Interestingly, it is shown for all mutants that their first refreeze and thaw do not 
affect the protein stability. Results have to be refined but this is an indication that we 
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could perform a refreeze and thaw during the manipulation of these proteins. However, 
we could not assume that protein stability would be maintained after several refreeze 
and thaw moments. 
 Globally, it is demonstrated that JIP3_LZII mutants possess melting 
temperatures between 30º-40ºC. Therefore, JIP3s’ dimer stability would not be high (to 
be validated). In order to distinguish precisely the importance of the buffer conditions 
for each JIP3_LZII mutant, as well as to eliminate measure errors and some significant 
differences (as shown for the first JIP3 LZII mutant, i.e.), triplicate measures will be 
performed. It is also shown that for JIP3_LZII_#7, there are no melting temperatures 
registered in any buffer conditions. Consequently, it is predicted that JIP3_LZII_#7 
possesses an incorrect protein folding, in comparison with other JIP3_LZII fragments. 
 
  
 SEC-MALS experiments of JIP3_LZII_#1 and mutants - SEC-MALS was 
realized for JIP3_LZII wild type and its mutants, aiming the knowledge of their 
oligomeric state, on similar buffer conditions of KLC1:JIP3_LZII interaction experiments 
performed by SPR assays (performed by P. Llinas, not shown in this manuscript). 
However, experiments failed, due to the presence of Tween 20 micelles during protein 
elution, as well as protein aggregation during the experiments. Column choice and 
buffer conditions (with emphasis on detergent concentration) are currently in 
optimisation. 
 
  
 Protein Crystallization assays of JIP3_LZII wild type and mutants – High 
Throughput Crystallisation Laboratory (HTX) collaboration - Crystallization Assays 
were performed with JIP3_LZII wild type and mutants on the HTX platform, Grenoble, 
France, in order to determine the 3D structure of the LZII domain of JIP3s. The aim to 
gain such structural information is to visualize if the JIP3_LZII wild type and/or mutants 
are parallel or anti-parallel coiled-coils, as well as the oligomerization state of the 
proteins. We expected that JIP3_LZII fragment exhibits dimeric parallel coiled-coil 
structure. However, recent structural data obtained in the lab suggest that this 
assumption could be wrong (Llinas et al., submitted).  
FCUP/ICBAS/I2BC 
Structural Characterization of JIP3/4 Leucine Zipper II Recruitment by kinesin1 
61 
 
 All JIP3_LZII wild type and mutants (11 proteins) were tested, as described on 
Materials and Methods, and some crystallization conditions were found as good for 
optimisation. There are microcrystals and crystal ursins in three conditions, with three 
different mutants, whose crystallization conditions will be optimised. On the Figure 31, 
it is shown photos from mentioned microcrystals. Also, on Table 11, JIP3_LZII 
fragments crystallized, precipitant conditions used and incubation temperatures are 
shown. 
 
Table 11 - Crystallization conditions of JIP3_LZII mutants. 
Correspondent 
on Figure 31 
JIP3_LZII mutant 
Precipitant conditions 
to optimize 
Temperature 
(ºC) 
A, B JIP3_LZII_#4 
0.1 M tri-sodium citrate pH 
5.6; 2.5 M 1.6-hexanediol 
4 
C JIP3_LZII_#4 
0.2 M sodium chloride; 0.1 
M sodium acetate pH 4.6; 
30 %(v/v) MPD 
20 
D 
JIP3_LZII_#3, 
JIP3_LZII_#5 
0.2 M magnesium formate 20 
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Figure 31 - JIP3_LZII crystallization conditions with the presence of microcrystals. To be optimised, in collaboration with 
HTX platform, Grenoble, France. Conditions shown on A, B, C and D are described on Table 11. B – Zoom picture of A, 
showing microcrystals with higher detail. 
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Protein-Protein interaction Characterization 
 
 KLC1_#0 and JIP4_LZII_#1, MST preliminary studies - Here, it is presented 
preliminary studies of KLC1_#0:JIP4_LZII_#1 interaction, by MST. Buffer optimisations 
were performed and, therefore, only best results achieved are shown. In these 
experiments, JIP4_LZII_#1 was used due to its high homology with JIP3_LZII, but also 
because of JIP4_LZII initial quantity required to perform MST, less expensive and 
easier to achieve, in comparison with JIP3_LZII mutants. JIP4_LZII_#1 had higher 
purification yields than JIP3_LZII mutants (not shown); thus, JIP4_LZII_#1 would be 
suitable to these MST assays.  
 KLC1_#0 was labelled with MO-L002 Monolight Protein Labeling Kit Green-
NHS, according with Nanotemper protocols.  
 
 
 
Figure 32 – MST experiments using labeled-KLC1_#0 and JIP4_LZII_#1. It is shown the results for each one of the 16 
capillaries tested, corresponding to 16 different JIP4 dilutions, all in the presence of the same quantity of KLC1-labeled. 
A – Graphic showing the variation of fluorescence detected, in function of time. B – Thermophoresis and T-Jump data 
analysis. 
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Figure 33 – Capillary Scan from MST experiments of labelled-KLC1 and JIP4_LZII. As it is evidenced by the graphic, 
the difference between initial fluorescence values of the capillaries is higher than 10%. Therefore, results could not be 
validated. 
 
 
 As shown on Figure 32, an interaction was detected between labeled-KLC1_#0 
and JIP4_LZII_#1. No protein aggregation was found during the experiments, along all 
the dilutions tested (confirmed by the graphic profile on Figure 32A). At the same time, 
on Figure 32B, it is exposed the existence of an inflection zone (between 103 and 105 
of  JIP4_LZII_#1 concentration (nano molar)), revealing the interval where the Kd 
of this interaction could be calculated. However, as indicated on Figure 33, the 
Capillary Scan made before the measurements showed a huge fluorescence difference 
between capillaries. Usually, in order to correctly calculate Kd values, the capillary scan 
should present fluorescence differences no higher than 10%, between them. Here, 
maybe there were protein adsorption to Standard Capillaries, or buffer conditions 
should be optimised for the complex. 
 Therefore, it was not possible to validate a Kd value for the complex, but it was 
confirmed an interaction with a Kd in the order of 0.5 uM.  
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 In the course of this project, we aim to characterize, from a structural 
perspective, the recruitment of JIP3/4_LZII by KLC1_TPR domain of kinesin1. To 
realize it, we intend to understand how the complex interaction takes place, obtaining 
structural and biophysical information of the complex, as well as knowledge about each 
JIP3/4_LZII and KLC1 interfaces. Based on a molecular docking performed by our 
collaborators, we purpose to identify and confirm regions and residues involved in the 
complex interaction. Before my arrival in the group, KLC1 interface was already 
investigated and validated (Phase1). Also, JIP3_LZII expression vectors were 
previously conceived. During my Master’s Project, I mainly participated on JIP3/4_LZII 
interface investigation (Phase 2). Thus, to be handled for complex interaction 
experiments, several  JIP3_LZII mutants, as well as new KLC1 fragments and mutants, 
were successfully produced and their structural integrity checked. I also participated on 
preliminary experiments to determine the 3D structure determination of the 
KLC1:JIP3/4_LZII complex by SAXS (Phase 3, not developed in this manuscript). 
Concerning the main objectives of the study, very positive advancements were 
achieved. 
 
 JIP3_LZII mutants were conceived in order to identify which residues of 
JIP3_LZII are involved in KLC1 interaction. To realize it, affinity binding experiments 
between KLC1 and JIP3_LZII mutants were performed using MST and SPR. However, 
in order to correctly describe these data, it is important to make sure that JIP3_LZII 
mutants produced are well folded. Indeed, if JIP3_LZII mutants are badly folded due to 
the mutation designed, interaction with KLC1 could be prevented. Therefore, one of my 
main objectives was to investigate the structural integrity of the JIP3_LZII mutants. 
Hence, I performed CD experiments in order to evaluate the secondary structure 
composition of each JIP3_LZII mutant. JIP3_LZII is a leucine zipper coiled-coil which 
folds as an alpha-helical protein. CD experiments predicted an average of alpha-helix 
structure around 80%, for almost of JIP3_LZII mutants. Accordingly with their protein 
sequence, (JIP3_LZII_#1 shown on Annexe 7), we assumed that all leucine zipper 
regions of the protein fragments designed have their secondary structure correctly 
folded, as alpha-helix domains. Indeed, after GST-tag cleavage, JIP3_LZII fragment is 
fused at their N-terminus to the remaining part of the rTEV cleavage site that should 
not adopt helical folding. Furthermore, JIP3 fragments possess 78 residues, where 11 
residues are outside the LZII, on the N-terminus. By the CD results, we could predict 
that 62 residues (80% of the protein sequence) are coiled-coil folded, near from 67 
residues which are a part of the LZII domain conceived. However, CD experiments 
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showed also that JIP3_LZII_#7 mutant is different with huge differences on its 
secondary structure composition, as shown on Figure 27. The JIP3_LZII_#7 mutant 
has alpha-helix percentage prediction around 34% in contrast to the 80% for other 
mutants. Thus, we considered that this mutation in JIP3_LZII prevents its correct 
(expected) folding. To conclude, affinity binding experiment between this JIP3_LZII 
mutant and KLC1 could not be correctly described and they will be removed from the 
study. Interestingly, as shown on Table 5, this mutant has the lowest purification yield 
during its protein expression on bacterial systems, comparing with other mutants. This 
difference could be due to a lower stability of the protein maybe caused by its incorrect 
folding.  
In parallel to CD experiments, I also performed nanoDSF assays in order to 
evaluate the stability of the JIP3_LZII mutants. NanoDSF approach allows to evaluate 
the heat denaturation curve of proteins following intrinsic tryptophan fluorescence. The 
JIP3_LZII fragments by their own possess no aromatic residues, but the construction of 
JIP3_LZII was conceived with a double tryptophan (WW) motif inserted between the 
protease cleavage site and the protein. Therefore, after GST-tag removal, two 
tryptophans are present at the N-terminus of the LZII. If we consider that JIP3_LZII 
coiled-coil is parallel, as expected by previous structural studies (Isabet T., et al., 
2009), there would have, at the N-terminus of the dimer, a patch of 4 tryptophan 
residues, two on each monomer, facing together. We anticipated that during heat 
denaturation process, dimer dissociation should produce a strong intrinsic tryptophan 
fluorescence signal. For all the JIP3_LZII mutants, except JIP3-LZII_#7, the Tm is 
relatively similar. The average Tm is around 30-35°C, which is unexpectedly low. 
Interestingly, no melting temperature could be determined for JIP3_LZII_#7 mutant. 
Therefore, it is not possible to achieve a heat denaturation profile for this mutant. In 
fact, this is in agreement with CD experiment results, and together, these elements 
support the conclusion that JIP3_LZII_#7 is not well folded and, thus, not stable. This 
data also confirms that JIP3_LZII_#7 should not be able to interact with KLC1 and will 
not be taken in account in our interpretation of affinity binding experiments. In 
conclusion, except for the JIP3_LZII_#7 mutant, we have evidences that all other 
JIP3_LZII mutants are well folded and could be used on interaction experiments. 
Finally, because a previous structural study in the group has allowed to 
crystallize a truncated form of JIP3_LZII (missing the 2 first heptad repeats) in an anti-
parallel arrangement, we are wondering if the full wild type JIP3_LZII or the mutants 
studied here adopt parallel or anti-parallel arrangement. To answer this question, I 
have taken the advantage of having the wild type and several mutants of the full 
FCUP/ICBAS/I2BC 
Structural Characterization of JIP3/4 Leucine Zipper II Recruitment by kinesin1 
69 
 
JIP3_LZII fragment produced and purified to perform crystallization assays, increasing 
the chance to find a crystal packing. Crystals were obtained for several mutants and 
should be reproduced and improved in the lab in order to solve the 3D structure. 
 
 Affinity binding experiments were performed to study KLC1:JIP3/4_LZII mutant 
interaction using SPR and MST. On the one hand, SPR experiments that have been 
done by P. Llinas in the group (in coll. Institut Pasteur) revealed that two mutants on 
the heptad 4 of JIP3_LZII prevent the interaction with KLC1, while the others only 
slightly affect the interaction. SPR results are not extensively developed in the 
manuscript. However, it is affirmed the use of the protein fragments produced during 
the project were successfully used during these experiments. In order to confirm these 
results, we will perform MST experiments. I performed (with P. Llinas) preliminary MST 
experiments, which confirm a Kd value of the complex KLC1_#0:JIP4_LZII_#1 in the 
range of micro Molar, as previously reported (Quyen et al., 2005 and SPR data). This 
result confirms that MST could be used to perform affinity binding experiments, which 
will be done in the near future. In conclusion of this part, Phase 2 (JIP3 interface 
validation) has to be reinforced with new JIP3_LZII mutants, which are now in 
preparation. Indeed, on the first part of Phase 2, point mutations were performed on the 
second, third and fourth heptad repeats of JIP3_LZII. Relevant point mutations found 
by SPR, affecting the formation of the complex, are positioned on the fourth heptad of 
JIP3_LZII. Therefore, with the aim of a deeply understanding of JIP3_LZII interface, a 
second group of protein mutants were planned to be conceived (part 2 of Phase 2). 
More point mutations will be performed on the fifth and sixth heptad, to better delimit 
the interaction zone of JIP3_LZII with KLC1. Furthermore, it will be arranged another 
group of mutants on the interaction zone (third and fourth heptads) to clarify and 
confirm JIP3_LZII interacting residues. Double mutation protein constructs will be also 
designed, in order to validate JIP3_LZII interface. After JIP3 new mutants’ conception, 
protein production will be made, following same optimised protocols during this project. 
At the same manner, JIP3_LZII characterization will be performed and completed to all 
new mutants, allowing the knowledge of their structural integrity (by CD, nanoDSF and 
SEC-MALS). Afterwards, binding assays will be performed by MST and SPR with new 
JIP3_LZII mutants and KLC1_#1, but also handling with KLC1_#2, not yet tested.  
 
In order to complement the site-directed mutagenesis and affinity binding 
studies (phases 1 and 2) to validate the KLC:JIP3_LZII docking model, the low 
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resolution 3D structure of the complex will be determined using SAXS (phase 3). I 
participated to the SAXS experiment (with P. Llinas) at the SWING beamline of the 
SOLEIL synchrotron, helping to collect preliminary but encouraging data for the 
complex. SAXS results are not extensively developed in the manuscript. However, it is 
affirmed the use of the protein fragments produced during the project was successfully 
used during experiments. These experiments are currently under optimisation.  
 
 The finalization of this project (new JIP3_LZII mutant production, SPR and MST 
assays, as well as SAXS experiments) will be a part of my PhD, which I will do in the 
group of Julie Ménétrey, at the “Institut de Biologie Intégrative de la Celulle”, joining the 
University of Paris-Saclay, at the doctoral school “Innovation Thérapeutique, du 
fondamental à l’appliqué”. In addition, I will realize the structural characterization of 
JIP3_LZI recruitment by the tail of KHC chain, from kinesin1 that correspond to the 
second mode of binding of JIP3/4 by Kinesin-1. Altogether, these two studies will allow 
to gain a full picture of how JIP3/4 proteins are recruited and transported by kinesin1, 
as well as their association with protein MAPK cascades in neurons. 
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Annexe 1 - Composition and use of Loading Buffer 5x. 
Loading Buffer x5 
Composition How to use 
0.06 M Tris-HCl pH 6.8 
Proteins were previously mixed with loading buffer, 
at final concentration of 1x. Thus protein samples were 
denatured by heat, at 95ºC. 
4% SDS 
25% Glycerol 
5% β-Mercaptoethanol 
0.1 % w/v Bromophenol blue 
 
 
 
Annexe 2 - Stacking and Runnung Compositions of SDS-PAGE. 
SDS-PAGE Composition 
Stacking gel Running Gel 
15% PolyAcrylamide  4% PolyAcrylamide  
0.44 M Tris-HCl pH 8.8 0.09 M Tris-HCl pH 6.8 
0.2% SDS 0.2% SDS 
0.1% TEMED 0.1% TEMED 
0.1 % AMPS 0.1 % AMPS 
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Annexe 3 - Buffer conditions optimised and used during Solubility and Minipurification tests. 
 
Buffer conditions used on Solubility and Minipurification 
tests 
 Buffer's funtion KLC1 fragments 
Lysis 
50 mM Hepes pH 8.0, 500 mM NaCl, 5 mM Imidazole pH 7.0, 10% 
Glycerol 
Wash 
50 mM Hepes pH 8.0, 500 mM NaCl, 5 mM Imidazole pH 7.0, 10% 
Glycerol 
Elution 
50 mM Hepes pH 8.0, 500 mM NaCl, 250 mM Imidazole pH 7.0, 
10% Glycerol 
  JIP3_LZII_#1 
Lysis 
50 mM Tris pH 8.0, 250 mM NaCl, 1 mM EDTA, 5 mM MgCl2, 
10% Glycerol 
Wash 
50 mM Tris pH 8.0, 250 mM NaCl, 1 mM EDTA, 5 mM MgCl2, 
10% Glycerol 
Elution 
50 mM Tris pH 8.0, 250 mM NaCl, 10 mM Reduced-Glutathione, 1 
mM EDTA, 5 mM MgCl2, 10% Glycerol 
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Annexe 4 - Protein Purification Buffers of KLC1 and JIP3_LZII fragments. 
  Buffer conditions used on KLC1 
fragments Purification   Chromatography 
Purification Step 
Buffer's 
name/function 
His-trap Affinity 
Lysis 
25 mM Hepes pH 8.0, 500 mM NaCl, 5 mM 
Imidazole pH 8.0, 10% Glycerol 
Wash 
50 mM Hepes pH 8.0, 500 mM NaCl, 20 mM 
Imidazole pH 8.0, 5% Glycerol 
Elution 
50 mM Hepes pH 8.0, 500 mM NaCl, 500 mM 
Imidazole pH 8.0, 5% Glycerol 
Size Exclusion  
Gel filtration and 
storage 
50 mM Hepes pH 8.0, 200 mM NaCl 
   
   
  Buffer conditions used on JIP3_LZII 
fragments Purification   Chromatography 
Purification Step 
Buffer's 
name/funtion 
1st GST-trap Affinity  
Lysis 
50 mM Tris pH 8.0, 1 M NaCl, 1 mM EDTA, 5 
mM MgCl2, 10% Glycerol, 0.05% Tween 20 
Wash 
50 mM Tris pH 8.0, 1 M NaCl, 1 mM EDTA, 
5% Glycerol, 0.05% Tween 20 
Elution 
50 mM Tris pH 8.0, 1 M NaCl, 1 mM EDTA, 
10 mM Reduced-Glutathione, 5% Glycerol, 
0.05% Tween 20 
His-trap Affinity 
His-buffer A 
50 mM Tris pH 8.0, 1 M NaCl, 5% Glycerol, 
0.05% Tween 20 
His-buffer B 
50 mM Tris pH 8.0, 1 M NaCl, 500 mM 
Imidazole 5% Glycerol, 0.05% Tween 20 
2nd GST-trap 
Affinity 
GST-buffer A 
50 mM Tris pH 8.0, 1 M NaCl, 5% Glycerol, 
0.05% Tween 20 
GST-buffer B 
50 mM Tris pH 8.0, 1 M NaCl, 10 mM 
Reduced-Glutathione 5% Glycerol, 0.05% 
Tween 20 
Size Exclusion  
Gel filtration and 
storage 
50 mM Tris pH 8.0, 150 mM NaCl, 0.05% 
Tween 20 
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Annexe 5 - Buffer Conditions analysed on KLC1 fragments, by TSA. Secondly , Tm values of TSA experiments for 
KLC1_#1 and KLC1_#3. 
TSA Conditions analysed on KLC1 fragments 
TSA Condition 
Buffer 
Conditions 
NaCl / 
mM 
KCL / 
mM 
TCEP / 
mM 
1 
50 mM 
Acetate pH 
5.0 
- - - 
2 50 - - 
3 200 - - 
4 500 - - 
5 200 - 10 
6 - 200 - 
7 
50 mM 
MES pH 
6.0 
- - - 
8 50 - - 
9 200 - - 
10 500 - - 
11 200 - 10 
12 - 200 - 
13 
50 mM 
HEPES pH 
7.0 
- - - 
14 50 - - 
15 200 - - 
16 500 - - 
17 200 - 10 
18 - 200 - 
19 
50 mM Tris 
pH 8.0 
- - - 
20 50 - - 
21 200 - - 
22 500 - - 
23 200 - 10 
24 - 200 - 
25 
50 mM 
Glycine pH 
9.0 
- - - 
26 50 - - 
27 200 - - 
28 500 - - 
29 200 - 10 
30  - 200 - 
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TSA Buffers 
Tested 
KLC1_#1 KLC1_#3 
Tm /ºC s Tm /ºC s 
1 41,43 0,75 74,51 0,43 
2 42,04 0,87 72,12 0,38 
3 39,71 3,09 69,4 0,62 
4 41,6 1,18 65,84 0,85 
5 Not defined / Not defined / 
6 38,61 4,95 68,24 0,62 
7 49,08 3,53 76,91 1,45 
8 Not defined / 76,25 0,5 
9 51,46 0,18 74,59 0,14 
10 52,23 0,1 73,69 0,57 
11 Not defined / Not defined / 
12 50,87 0,17 73,36 0,8 
13 45,9 0,09 81,78 0,52 
14 52,72 0,24 81,62 0,14 
15 55,13 0,17 81,45 0,25 
16 58,44 0,09 81,78 0,14 
17 Not defined / Not defined / 
18 55,71 0,09 81,37 0,14 
19 44,45 0,18 83,1 0,57 
20 50,54 0,28 83,51 0,29 
21 55,16 0,09 83,93 0,25 
22 58,49 0,09 84,26 0,14 
23 Not defined / Not defined / 
24 55,61 0 83,85 0,14 
25 44,48 0,16 84,34 0,14 
26 48,58 0,49 84,59 0,14 
27 54,31 0,33 84,84 0,14 
28 57,52 0,09 85 0,14 
29 Not defined / Not defined 0,14 
30 54,25 0,19 84,75 0,14 
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Annexe 6 - Buffer conditions analysed on JIP3_LZII_#10, by nanoDSF. Various experiment buffer compositions 
analysed on JIP3_LZIIs, by nanoDSF. 
nanoDSF Conditions analysed on JIP3_LZII_#10 
nanoDSF Condition Buffer Conditions Imidazole / mM NaCl / mM 
1 25 mM MES pH 6.5 - 
100 
2 25 mM Hepes pH 7.0 - 
3 25 mM Hepes pH 7.5 - 
4 25 mM Tris pH 8.0 - 
5 25 mM MES pH 6.5 - 
200 
6 25 mM Hepes pH 7.0 - 
7 25 mM Hepes pH 7.5 - 
8 25 mM Tris pH 8.0 - 
9 25 mM MES pH 6.5 - 
300 
10 25 mM Hepes pH 7.0 - 
11 25 mM Hepes pH 7.5 - 
12 25 mM Tris pH 8.0 - 
13 25 mM MES pH 6.5 
50 
100 
14 25 mM Hepes pH 7.0 
15 25 mM Hepes pH 7.5 
16 25 mM Tris pH 8.0 
17 25 mM MES pH 6.5 
200 
18 25 mM Hepes pH 7.0 
19 25 mM Hepes pH 7.5 
20 25 mM Tris pH 8.0 
21 25 mM MES pH 6.5 300 
 
nanoDSF Buffer Conditions analysed on JIP3_LZII fragments 
Buffer 
Designation 
JIP3_LZII Experiments were 
buffer is used 
Composition 
GF 
Size Exclusion Chromatography and 
JIP3_LZII Storage 
50 mM Tris pH 8.0, 150 
mM NaCl, 0.05% Tween 20 
CD Circular Dichroism  
20 mM phosphate pH 7.0, 
150 mM NaF, 0.05% 
Tween 20 
SPR Surface Plasmon Resonance 
25 mM Hepes pH 7.0, 500 
mM NaCl, 5 mM MgCl2, 
0.05 % Tween 20, 100 uM 
EDTA 
GF freeze 
Same as GF, after re-freeze and 
thaw 
50 mM Tris pH 8.0, 150 
mM NaCl, 0.05% Tween 20 
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Annexe 7 - KLC1_#1 and JIP3_LZII_#1 protein fragment sequences 
KLC_#1 protein sequence (His-tagged) 
MGYEIPARLRTLHNLVIQYASQGRYEVAVPLCKQALEDLEKTSGHDHPDVATMLNILA
LVYRDQNKYKDAANLLNDALAIREKTLGKDHPAVAATLNNLAVLYGKRGKYKEAEPLC
KRALEIREKVLGKDHPDVAKQLNNLALLCQNQGKYEEVEYYYQRALEIYQTKLGPDDP
NVAKTKNNLASCYLKQGKFKQAETLYKEILTRAHEREFGSVDDENKPIWMHAEEREE
CKGKQKDGTSFGEYGGWYKACKVDSPTVTTTLKNLGALYRRQGKFEAAETLEEAAM
RSRKQGLDNVHENLYFQGLEHHHHHH 
  
JIP3_LZII_#1 protein sequence (GST-tagged) 
MSPILGYWKIKGLVQPTRLLLEYLEEKYEEHLYERDEGDKWRNKKFELGLEFPNLPYYI
DGDVKLTQSMAIIRYIADKHNMLGGCPKERAEISMLEGAVLDIRYGVSRIAYSKDFETL
KVDFLSKLPEMLKMFEDRLCHKTYLNGDHVTHPDFMLYDALDVVLYMDPMCLDAFPK
LVCFKKRIEAIPQIDKYLKSSKYIAWPLQGWQATFGGGDHPPKIDTTENLYFQGAMDW
WFMGKEVGNLLLENSQLLETKNALNVVKNDLIAKVDQLSGEQEVLRGELEAAKQAKV
KLENRIKELEEELKRV 
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Annexe 8 – Crystallization Solubility Screening, performed on the laboratory. Usually, we use this screening on 
crystallization trials protein fragments in study. We aim to obtain information about protein concentration, pH and salt 
conditions that we could use to achieved protein crystals. 
Crystallization Solubility Screening, used to KLC1_#1 crystallization 
assays 
 
1.5 M AMSO4 ; 
0.1 M MES pH 
6.0 
 
1.9 M AMSO4 ; 
0.1 M MES pH 
6.0 
 
2.3 M AMSO4 ; 
0.1 M MES pH 
6.0 
 
2.7 M AMSO4 ; 
0.1 M MES pH 
6.0 
 
3.1 M AMSO4 ; 
0.1 M MES pH 
6.0 
 
1.5 M AMSO4 ; 
0.1 M Tris pH 
8.0 
 
1.9 M AMSO4 ; 
0.1 M Tris pH 
8.0 
 
2.3 M AMSO4 ; 
0.1 M Tris pH 
8.0 
 
2.7 M AMSO4 ; 
0.1 M Tris pH 
8.0 
 
3.1 M AMSO4; 
0.1 M Tris pH 
8.0 
 
15% KH2PO4 ; 
0.1 M MES pH 
6.0 
 
20% KH2PO4 ; 
0.1 M MES pH 
6.0 
 
25% KH2PO4 ; 
0.1 M MES pH 
6.0 
 
30% KH2PO4 ; 
0.1 M MES pH 
6.0 
 
35% KH2PO4 ; 
0.1 M MES pH 
6.0 
 
15% KH2PO4 ; 
0.1 M Tris pH 
8.0 
 
20% KH2PO4 ; 
0.1 M Tris pH 
8.0 
 
25% KH2PO4 ; 
0.1 M Tris pH 
8.0 
 
30% KH2PO4 ; 
0.1 M Tris pH 
8.0 
 
35% KH2PO4 ; 
0.1 M Tris pH 
8.0 
 
 
 
Annexe 9 - JIP3_LZII Secondary Structure Prediction values, calculated as described, by CD experiments. 
Protein Secondary Structure Prediction values, 
calculated by CD 
JIP3_LZIIs Helix Strand Turn Random Total 
JIP3_LZII_#1 80,30 6,70 3,75 9,45 100,20 
JIP3_LZII_#2 73,00 6,85 5,45 14,65 99,95 
JIP3_LZII_#3 80,70 5,00 4,80 9,40 99,90 
JIP3_LZII_#4 67,35 9,10 7,95 15,80 100,20 
JIP3_LZII_#5 77,20 4,70 4,80 10,35 97,05 
JIP3_LZII_#6 79,25 6,70 4,30 9,30 99,55 
JIP3_LZII_#7_1 34,60 17,50 18,25 29,65 100,00 
JIP3_LZII_#7_2 33,65 16,30 18,30 31,90 100,15 
JIP3_LZII_#8 77,05 5,15 4,95 12,95 100,10 
JIP3_LZII_#9 80,95 5,55 5,10 8,20 99,80 
JIP3_LZII_#10 79,10 6,60 5,65 9,35 100,70 
JIP3_LZII_#11 72,75 7,55 5,95 13,80 100,05 
 
 
